Global Radiopharmaceuticals for Diagnosis Market Research Report 2025(Status and Outlook)
Report Overview
Diagnostic radiopharmaceuticals are a special class of drugs used in medical imaging diagnosis. These drugs contain radioactive isotopes that can locate and emit radiation signals in specific organs or tissues in the body. Through these signals, doctors can use nuclear medicine imaging equipment (such as single photon emission computed tomography (SPECT) and positron emission tomography (PET)) to detect and evaluate the presence and extent of various diseases, such as cancer, heart disease, thyroid dysfunction, brain disease, etc.
This report provides a deep insight into the global Radiopharmaceuticals for Diagnosis market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Radiopharmaceuticals for Diagnosis Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Radiopharmaceuticals for Diagnosis market in any manner.
Global Radiopharmaceuticals for Diagnosis Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Atom High-tech Co.
Ltd.
Shanghai Xinke Pharmaceutical Co.
Ltd.
Guangdong Xi'ai Pharmaceutical Co.
Ltd.
Wuxi Jiangyuan Industrial Technology and Trade Co.
Ltd. Jiangyuan Pharmaceutical Factory
Guangzhou Atom High-tech Isotope Pharmaceutical Co.
Ltd.
Chengdu Yunke Pharmaceutical Co.
Ltd.
Shanghai Atom Kexing Pharmaceutical Co.
Ltd.
Shenzhen Larven Bioengineering Technology Co.
Ltd.
Ningbo Jun'an Pharmaceutical Technology Co.
Ltd.
Beijing Zhibo High-tech Biotechnology Co.
Ltd.
Tianjin Said Biopharmaceutical Co.
Ltd.
Chengdu Zhonghe Gaotong Isotope Co.
Ltd.
Chengdu Xinke Pharmaceutical Co.
Ltd.
Jubilant Radiopharma
PDRadiopharma Inc.
GE Healthcare Ltd
DOE IP
Market Segmentation (by Type)
Technetium [99mTc] Dithiodithiocarbamate
Technetium [99mTc] Polymerized Albumin
Technetium [99mTc] Pentetate
Strontium [89Sr] Chloride
Iodine [125I] Sealed Seed Source
Sodium Iodide [131I]
Other
Market Segmentation (by Application)
Hospital
Clinic
Other
Geographic Segmentation
North America (USA, Canada, Mexico)
Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
South America (Brazil, Argentina, Columbia, Rest of South America)
The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the Radiopharmaceuticals for Diagnosis Market
Overview of the regional outlook of the Radiopharmaceuticals for Diagnosis Market:
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Radiopharmaceuticals for Diagnosis Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Radiopharmaceuticals for Diagnosis, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
Provides insight into the market through Value Chain
Market dynamics scenario, along with growth opportunities of the market in the years to come
6-month post-sales analyst support
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Diagnostic radiopharmaceuticals are a special class of drugs used in medical imaging diagnosis. These drugs contain radioactive isotopes that can locate and emit radiation signals in specific organs or tissues in the body. Through these signals, doctors can use nuclear medicine imaging equipment (such as single photon emission computed tomography (SPECT) and positron emission tomography (PET)) to detect and evaluate the presence and extent of various diseases, such as cancer, heart disease, thyroid dysfunction, brain disease, etc.
This report provides a deep insight into the global Radiopharmaceuticals for Diagnosis market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Radiopharmaceuticals for Diagnosis Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Radiopharmaceuticals for Diagnosis market in any manner.
Global Radiopharmaceuticals for Diagnosis Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Atom High-tech Co.
Ltd.
Shanghai Xinke Pharmaceutical Co.
Ltd.
Guangdong Xi'ai Pharmaceutical Co.
Ltd.
Wuxi Jiangyuan Industrial Technology and Trade Co.
Ltd. Jiangyuan Pharmaceutical Factory
Guangzhou Atom High-tech Isotope Pharmaceutical Co.
Ltd.
Chengdu Yunke Pharmaceutical Co.
Ltd.
Shanghai Atom Kexing Pharmaceutical Co.
Ltd.
Shenzhen Larven Bioengineering Technology Co.
Ltd.
Ningbo Jun'an Pharmaceutical Technology Co.
Ltd.
Beijing Zhibo High-tech Biotechnology Co.
Ltd.
Tianjin Said Biopharmaceutical Co.
Ltd.
Chengdu Zhonghe Gaotong Isotope Co.
Ltd.
Chengdu Xinke Pharmaceutical Co.
Ltd.
Jubilant Radiopharma
PDRadiopharma Inc.
GE Healthcare Ltd
DOE IP
Market Segmentation (by Type)
Technetium [99mTc] Dithiodithiocarbamate
Technetium [99mTc] Polymerized Albumin
Technetium [99mTc] Pentetate
Strontium [89Sr] Chloride
Iodine [125I] Sealed Seed Source
Sodium Iodide [131I]
Other
Market Segmentation (by Application)
Hospital
Clinic
Other
Geographic Segmentation
North America (USA, Canada, Mexico)
Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
South America (Brazil, Argentina, Columbia, Rest of South America)
The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the Radiopharmaceuticals for Diagnosis Market
Overview of the regional outlook of the Radiopharmaceuticals for Diagnosis Market:
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Radiopharmaceuticals for Diagnosis Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Radiopharmaceuticals for Diagnosis, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
Provides insight into the market through Value Chain
Market dynamics scenario, along with growth opportunities of the market in the years to come
6-month post-sales analyst support
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE
1.1 Market Definition and Statistical Scope of Radiopharmaceuticals for Diagnosis
1.2 Key Market Segments
1.2.1 Radiopharmaceuticals for Diagnosis Segment by Type
1.2.2 Radiopharmaceuticals for Diagnosis Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 RADIOPHARMACEUTICALS FOR DIAGNOSIS MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Radiopharmaceuticals for Diagnosis Market Size (M USD) Estimates and Forecasts (2020-2033)
2.1.2 Global Radiopharmaceuticals for Diagnosis Sales Estimates and Forecasts (2020-2033)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 RADIOPHARMACEUTICALS FOR DIAGNOSIS MARKET COMPETITIVE LANDSCAPE
3.1 Company Assessment Quadrant
3.2 Global Radiopharmaceuticals for Diagnosis Product Life Cycle
3.3 Global Radiopharmaceuticals for Diagnosis Sales by Manufacturers (2020-2025)
3.4 Global Radiopharmaceuticals for Diagnosis Revenue Market Share by Manufacturers (2020-2025)
3.5 Radiopharmaceuticals for Diagnosis Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Radiopharmaceuticals for Diagnosis Average Price by Manufacturers (2020-2025)
3.7 Manufacturers’ Manufacturing Sites, Areas Served, and Product Types
3.8 Radiopharmaceuticals for Diagnosis Market Competitive Situation and Trends
3.8.1 Radiopharmaceuticals for Diagnosis Market Concentration Rate
3.8.2 Global 5 and 10 Largest Radiopharmaceuticals for Diagnosis Players Market Share by Revenue
3.8.3 Mergers & Acquisitions, Expansion
4 RADIOPHARMACEUTICALS FOR DIAGNOSIS INDUSTRY CHAIN ANALYSIS
4.1 Radiopharmaceuticals for Diagnosis Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF RADIOPHARMACEUTICALS FOR DIAGNOSIS MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global Radiopharmaceuticals for Diagnosis Market Porter's Five Forces Analysis
5.6.1 Global Trade Frictions
5.6.2 U.S. Tariff Policy – April 2025
5.6.3 Global Trade Frictions and Their Impacts to Radiopharmaceuticals for Diagnosis Market
5.7 ESG Ratings of Leading Companies
6 RADIOPHARMACEUTICALS FOR DIAGNOSIS MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Radiopharmaceuticals for Diagnosis Sales Market Share by Type (2020-2025)
6.3 Global Radiopharmaceuticals for Diagnosis Market Size Market Share by Type (2020-2025)
6.4 Global Radiopharmaceuticals for Diagnosis Price by Type (2020-2025)
7 RADIOPHARMACEUTICALS FOR DIAGNOSIS MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Radiopharmaceuticals for Diagnosis Market Sales by Application (2020-2025)
7.3 Global Radiopharmaceuticals for Diagnosis Market Size (M USD) by Application (2020-2025)
7.4 Global Radiopharmaceuticals for Diagnosis Sales Growth Rate by Application (2020-2025)
8 RADIOPHARMACEUTICALS FOR DIAGNOSIS MARKET SALES BY REGION
8.1 Global Radiopharmaceuticals for Diagnosis Sales by Region
8.1.1 Global Radiopharmaceuticals for Diagnosis Sales by Region
8.1.2 Global Radiopharmaceuticals for Diagnosis Sales Market Share by Region
8.2 Global Radiopharmaceuticals for Diagnosis Market Size by Region
8.2.1 Global Radiopharmaceuticals for Diagnosis Market Size by Region
8.2.2 Global Radiopharmaceuticals for Diagnosis Market Size Market Share by Region
8.3 North America
8.3.1 North America Radiopharmaceuticals for Diagnosis Sales by Country
8.3.2 North America Radiopharmaceuticals for Diagnosis Market Size by Country
8.3.3 U.S. Market Overview
8.3.4 Canada Market Overview
8.3.5 Mexico Market Overview
8.4 Europe
8.4.1 Europe Radiopharmaceuticals for Diagnosis Sales by Country
8.4.2 Europe Radiopharmaceuticals for Diagnosis Market Size by Country
8.4.3 Germany Market Overview
8.4.4 France Market Overview
8.4.5 U.K. Market Overview
8.4.6 Italy Market Overview
8.4.7 Spain Market Overview
8.5 Asia Pacific
8.5.1 Asia Pacific Radiopharmaceuticals for Diagnosis Sales by Region
8.5.2 Asia Pacific Radiopharmaceuticals for Diagnosis Market Size by Region
8.5.3 China Market Overview
8.5.4 Japan Market Overview
8.5.5 South Korea Market Overview
8.5.6 India Market Overview
8.5.7 Southeast Asia Market Overview
8.6 South America
8.6.1 South America Radiopharmaceuticals for Diagnosis Sales by Country
8.6.2 South America Radiopharmaceuticals for Diagnosis Market Size by Country
8.6.3 Brazil Market Overview
8.6.4 Argentina Market Overview
8.6.5 Columbia Market Overview
8.7 Middle East and Africa
8.7.1 Middle East and Africa Radiopharmaceuticals for Diagnosis Sales by Region
8.7.2 Middle East and Africa Radiopharmaceuticals for Diagnosis Market Size by Region
8.7.3 Saudi Arabia Market Overview
8.7.4 UAE Market Overview
8.7.5 Egypt Market Overview
8.7.6 Nigeria Market Overview
8.7.7 South Africa Market Overview
9 RADIOPHARMACEUTICALS FOR DIAGNOSIS MARKET PRODUCTION BY REGION
9.1 Global Production of Radiopharmaceuticals for Diagnosis by Region(2020-2025)
9.2 Global Radiopharmaceuticals for Diagnosis Revenue Market Share by Region (2020-2025)
9.3 Global Radiopharmaceuticals for Diagnosis Production, Revenue, Price and Gross Margin (2020-2025)
9.4 North America Radiopharmaceuticals for Diagnosis Production
9.4.1 North America Radiopharmaceuticals for Diagnosis Production Growth Rate (2020-2025)
9.4.2 North America Radiopharmaceuticals for Diagnosis Production, Revenue, Price and Gross Margin (2020-2025)
9.5 Europe Radiopharmaceuticals for Diagnosis Production
9.5.1 Europe Radiopharmaceuticals for Diagnosis Production Growth Rate (2020-2025)
9.5.2 Europe Radiopharmaceuticals for Diagnosis Production, Revenue, Price and Gross Margin (2020-2025)
9.6 Japan Radiopharmaceuticals for Diagnosis Production (2020-2025)
9.6.1 Japan Radiopharmaceuticals for Diagnosis Production Growth Rate (2020-2025)
9.6.2 Japan Radiopharmaceuticals for Diagnosis Production, Revenue, Price and Gross Margin (2020-2025)
9.7 China Radiopharmaceuticals for Diagnosis Production (2020-2025)
9.7.1 China Radiopharmaceuticals for Diagnosis Production Growth Rate (2020-2025)
9.7.2 China Radiopharmaceuticals for Diagnosis Production, Revenue, Price and Gross Margin (2020-2025)
10 KEY COMPANIES PROFILE
10.1 Atom High-tech Co.
10.1.1 Atom High-tech Co. Basic Information
10.1.2 Atom High-tech Co. Radiopharmaceuticals for Diagnosis Product Overview
10.1.3 Atom High-tech Co. Radiopharmaceuticals for Diagnosis Product Market Performance
10.1.4 Atom High-tech Co. Business Overview
10.1.5 Atom High-tech Co. SWOT Analysis
10.1.6 Atom High-tech Co. Recent Developments
10.2 Ltd.
10.2.1 Ltd. Basic Information
10.2.2 Ltd. Radiopharmaceuticals for Diagnosis Product Overview
10.2.3 Ltd. Radiopharmaceuticals for Diagnosis Product Market Performance
10.2.4 Ltd. Business Overview
10.2.5 Ltd. SWOT Analysis
10.2.6 Ltd. Recent Developments
10.3 Shanghai Xinke Pharmaceutical Co.
10.3.1 Shanghai Xinke Pharmaceutical Co. Basic Information
10.3.2 Shanghai Xinke Pharmaceutical Co. Radiopharmaceuticals for Diagnosis Product Overview
10.3.3 Shanghai Xinke Pharmaceutical Co. Radiopharmaceuticals for Diagnosis Product Market Performance
10.3.4 Shanghai Xinke Pharmaceutical Co. Business Overview
10.3.5 Shanghai Xinke Pharmaceutical Co. SWOT Analysis
10.3.6 Shanghai Xinke Pharmaceutical Co. Recent Developments
10.4 Ltd.
10.4.1 Ltd. Basic Information
10.4.2 Ltd. Radiopharmaceuticals for Diagnosis Product Overview
10.4.3 Ltd. Radiopharmaceuticals for Diagnosis Product Market Performance
10.4.4 Ltd. Business Overview
10.4.5 Ltd. Recent Developments
10.5 Guangdong Xi'ai Pharmaceutical Co.
10.5.1 Guangdong Xi'ai Pharmaceutical Co. Basic Information
10.5.2 Guangdong Xi'ai Pharmaceutical Co. Radiopharmaceuticals for Diagnosis Product Overview
10.5.3 Guangdong Xi'ai Pharmaceutical Co. Radiopharmaceuticals for Diagnosis Product Market Performance
10.5.4 Guangdong Xi'ai Pharmaceutical Co. Business Overview
10.5.5 Guangdong Xi'ai Pharmaceutical Co. Recent Developments
10.6 Ltd.
10.6.1 Ltd. Basic Information
10.6.2 Ltd. Radiopharmaceuticals for Diagnosis Product Overview
10.6.3 Ltd. Radiopharmaceuticals for Diagnosis Product Market Performance
10.6.4 Ltd. Business Overview
10.6.5 Ltd. Recent Developments
10.7 Wuxi Jiangyuan Industrial Technology and Trade Co.
10.7.1 Wuxi Jiangyuan Industrial Technology and Trade Co. Basic Information
10.7.2 Wuxi Jiangyuan Industrial Technology and Trade Co. Radiopharmaceuticals for Diagnosis Product Overview
10.7.3 Wuxi Jiangyuan Industrial Technology and Trade Co. Radiopharmaceuticals for Diagnosis Product Market Performance
10.7.4 Wuxi Jiangyuan Industrial Technology and Trade Co. Business Overview
10.7.5 Wuxi Jiangyuan Industrial Technology and Trade Co. Recent Developments
10.8 Ltd. Jiangyuan Pharmaceutical Factory
10.8.1 Ltd. Jiangyuan Pharmaceutical Factory Basic Information
10.8.2 Ltd. Jiangyuan Pharmaceutical Factory Radiopharmaceuticals for Diagnosis Product Overview
10.8.3 Ltd. Jiangyuan Pharmaceutical Factory Radiopharmaceuticals for Diagnosis Product Market Performance
10.8.4 Ltd. Jiangyuan Pharmaceutical Factory Business Overview
10.8.5 Ltd. Jiangyuan Pharmaceutical Factory Recent Developments
10.9 Guangzhou Atom High-tech Isotope Pharmaceutical Co.
10.9.1 Guangzhou Atom High-tech Isotope Pharmaceutical Co. Basic Information
10.9.2 Guangzhou Atom High-tech Isotope Pharmaceutical Co. Radiopharmaceuticals for Diagnosis Product Overview
10.9.3 Guangzhou Atom High-tech Isotope Pharmaceutical Co. Radiopharmaceuticals for Diagnosis Product Market Performance
10.9.4 Guangzhou Atom High-tech Isotope Pharmaceutical Co. Business Overview
10.9.5 Guangzhou Atom High-tech Isotope Pharmaceutical Co. Recent Developments
10.10 Ltd.
10.10.1 Ltd. Basic Information
10.10.2 Ltd. Radiopharmaceuticals for Diagnosis Product Overview
10.10.3 Ltd. Radiopharmaceuticals for Diagnosis Product Market Performance
10.10.4 Ltd. Business Overview
10.10.5 Ltd. Recent Developments
10.11 Chengdu Yunke Pharmaceutical Co.
10.11.1 Chengdu Yunke Pharmaceutical Co. Basic Information
10.11.2 Chengdu Yunke Pharmaceutical Co. Radiopharmaceuticals for Diagnosis Product Overview
10.11.3 Chengdu Yunke Pharmaceutical Co. Radiopharmaceuticals for Diagnosis Product Market Performance
10.11.4 Chengdu Yunke Pharmaceutical Co. Business Overview
10.11.5 Chengdu Yunke Pharmaceutical Co. Recent Developments
10.12 Ltd.
10.12.1 Ltd. Basic Information
10.12.2 Ltd. Radiopharmaceuticals for Diagnosis Product Overview
10.12.3 Ltd. Radiopharmaceuticals for Diagnosis Product Market Performance
10.12.4 Ltd. Business Overview
10.12.5 Ltd. Recent Developments
10.13 Shanghai Atom Kexing Pharmaceutical Co.
10.13.1 Shanghai Atom Kexing Pharmaceutical Co. Basic Information
10.13.2 Shanghai Atom Kexing Pharmaceutical Co. Radiopharmaceuticals for Diagnosis Product Overview
10.13.3 Shanghai Atom Kexing Pharmaceutical Co. Radiopharmaceuticals for Diagnosis Product Market Performance
10.13.4 Shanghai Atom Kexing Pharmaceutical Co. Business Overview
10.13.5 Shanghai Atom Kexing Pharmaceutical Co. Recent Developments
10.14 Ltd.
10.14.1 Ltd. Basic Information
10.14.2 Ltd. Radiopharmaceuticals for Diagnosis Product Overview
10.14.3 Ltd. Radiopharmaceuticals for Diagnosis Product Market Performance
10.14.4 Ltd. Business Overview
10.14.5 Ltd. Recent Developments
10.15 Shenzhen Larven Bioengineering Technology Co.
10.15.1 Shenzhen Larven Bioengineering Technology Co. Basic Information
10.15.2 Shenzhen Larven Bioengineering Technology Co. Radiopharmaceuticals for Diagnosis Product Overview
10.15.3 Shenzhen Larven Bioengineering Technology Co. Radiopharmaceuticals for Diagnosis Product Market Performance
10.15.4 Shenzhen Larven Bioengineering Technology Co. Business Overview
10.15.5 Shenzhen Larven Bioengineering Technology Co. Recent Developments
10.16 Ltd.
10.16.1 Ltd. Basic Information
10.16.2 Ltd. Radiopharmaceuticals for Diagnosis Product Overview
10.16.3 Ltd. Radiopharmaceuticals for Diagnosis Product Market Performance
10.16.4 Ltd. Business Overview
10.16.5 Ltd. Recent Developments
10.17 Ningbo Jun'an Pharmaceutical Technology Co.
10.17.1 Ningbo Jun'an Pharmaceutical Technology Co. Basic Information
10.17.2 Ningbo Jun'an Pharmaceutical Technology Co. Radiopharmaceuticals for Diagnosis Product Overview
10.17.3 Ningbo Jun'an Pharmaceutical Technology Co. Radiopharmaceuticals for Diagnosis Product Market Performance
10.17.4 Ningbo Jun'an Pharmaceutical Technology Co. Business Overview
10.17.5 Ningbo Jun'an Pharmaceutical Technology Co. Recent Developments
10.18 Ltd.
10.18.1 Ltd. Basic Information
10.18.2 Ltd. Radiopharmaceuticals for Diagnosis Product Overview
10.18.3 Ltd. Radiopharmaceuticals for Diagnosis Product Market Performance
10.18.4 Ltd. Business Overview
10.18.5 Ltd. Recent Developments
10.19 Beijing Zhibo High-tech Biotechnology Co.
10.19.1 Beijing Zhibo High-tech Biotechnology Co. Basic Information
10.19.2 Beijing Zhibo High-tech Biotechnology Co. Radiopharmaceuticals for Diagnosis Product Overview
10.19.3 Beijing Zhibo High-tech Biotechnology Co. Radiopharmaceuticals for Diagnosis Product Market Performance
10.19.4 Beijing Zhibo High-tech Biotechnology Co. Business Overview
10.19.5 Beijing Zhibo High-tech Biotechnology Co. Recent Developments
10.20 Ltd.
10.20.1 Ltd. Basic Information
10.20.2 Ltd. Radiopharmaceuticals for Diagnosis Product Overview
10.20.3 Ltd. Radiopharmaceuticals for Diagnosis Product Market Performance
10.20.4 Ltd. Business Overview
10.20.5 Ltd. Recent Developments
10.21 Tianjin Said Biopharmaceutical Co.
10.21.1 Tianjin Said Biopharmaceutical Co. Basic Information
10.21.2 Tianjin Said Biopharmaceutical Co. Radiopharmaceuticals for Diagnosis Product Overview
10.21.3 Tianjin Said Biopharmaceutical Co. Radiopharmaceuticals for Diagnosis Product Market Performance
10.21.4 Tianjin Said Biopharmaceutical Co. Business Overview
10.21.5 Tianjin Said Biopharmaceutical Co. Recent Developments
10.22 Ltd.
10.22.1 Ltd. Basic Information
10.22.2 Ltd. Radiopharmaceuticals for Diagnosis Product Overview
10.22.3 Ltd. Radiopharmaceuticals for Diagnosis Product Market Performance
10.22.4 Ltd. Business Overview
10.22.5 Ltd. Recent Developments
10.23 Chengdu Zhonghe Gaotong Isotope Co.
10.23.1 Chengdu Zhonghe Gaotong Isotope Co. Basic Information
10.23.2 Chengdu Zhonghe Gaotong Isotope Co. Radiopharmaceuticals for Diagnosis Product Overview
10.23.3 Chengdu Zhonghe Gaotong Isotope Co. Radiopharmaceuticals for Diagnosis Product Market Performance
10.23.4 Chengdu Zhonghe Gaotong Isotope Co. Business Overview
10.23.5 Chengdu Zhonghe Gaotong Isotope Co. Recent Developments
10.24 Ltd.
10.24.1 Ltd. Basic Information
10.24.2 Ltd. Radiopharmaceuticals for Diagnosis Product Overview
10.24.3 Ltd. Radiopharmaceuticals for Diagnosis Product Market Performance
10.24.4 Ltd. Business Overview
10.24.5 Ltd. Recent Developments
10.25 Chengdu Xinke Pharmaceutical Co.
10.25.1 Chengdu Xinke Pharmaceutical Co. Basic Information
10.25.2 Chengdu Xinke Pharmaceutical Co. Radiopharmaceuticals for Diagnosis Product Overview
10.25.3 Chengdu Xinke Pharmaceutical Co. Radiopharmaceuticals for Diagnosis Product Market Performance
10.25.4 Chengdu Xinke Pharmaceutical Co. Business Overview
10.25.5 Chengdu Xinke Pharmaceutical Co. Recent Developments
10.26 Ltd.
10.26.1 Ltd. Basic Information
10.26.2 Ltd. Radiopharmaceuticals for Diagnosis Product Overview
10.26.3 Ltd. Radiopharmaceuticals for Diagnosis Product Market Performance
10.26.4 Ltd. Business Overview
10.26.5 Ltd. Recent Developments
10.27 Jubilant Radiopharma
10.27.1 Jubilant Radiopharma Basic Information
10.27.2 Jubilant Radiopharma Radiopharmaceuticals for Diagnosis Product Overview
10.27.3 Jubilant Radiopharma Radiopharmaceuticals for Diagnosis Product Market Performance
10.27.4 Jubilant Radiopharma Business Overview
10.27.5 Jubilant Radiopharma Recent Developments
10.28 PDRadiopharma Inc.
10.28.1 PDRadiopharma Inc. Basic Information
10.28.2 PDRadiopharma Inc. Radiopharmaceuticals for Diagnosis Product Overview
10.28.3 PDRadiopharma Inc. Radiopharmaceuticals for Diagnosis Product Market Performance
10.28.4 PDRadiopharma Inc. Business Overview
10.28.5 PDRadiopharma Inc. Recent Developments
10.29 GE Healthcare Ltd
10.29.1 GE Healthcare Ltd Basic Information
10.29.2 GE Healthcare Ltd Radiopharmaceuticals for Diagnosis Product Overview
10.29.3 GE Healthcare Ltd Radiopharmaceuticals for Diagnosis Product Market Performance
10.29.4 GE Healthcare Ltd Business Overview
10.29.5 GE Healthcare Ltd Recent Developments
10.30 DOE IP
10.30.1 DOE IP Basic Information
10.30.2 DOE IP Radiopharmaceuticals for Diagnosis Product Overview
10.30.3 DOE IP Radiopharmaceuticals for Diagnosis Product Market Performance
10.30.4 DOE IP Business Overview
10.30.5 DOE IP Recent Developments
11 RADIOPHARMACEUTICALS FOR DIAGNOSIS MARKET FORECAST BY REGION
11.1 Global Radiopharmaceuticals for Diagnosis Market Size Forecast
11.2 Global Radiopharmaceuticals for Diagnosis Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Radiopharmaceuticals for Diagnosis Market Size Forecast by Country
11.2.3 Asia Pacific Radiopharmaceuticals for Diagnosis Market Size Forecast by Region
11.2.4 South America Radiopharmaceuticals for Diagnosis Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Sales of Radiopharmaceuticals for Diagnosis by Country
12 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2033)
12.1 Global Radiopharmaceuticals for Diagnosis Market Forecast by Type (2026-2033)
12.1.1 Global Forecasted Sales of Radiopharmaceuticals for Diagnosis by Type (2026-2033)
12.1.2 Global Radiopharmaceuticals for Diagnosis Market Size Forecast by Type (2026-2033)
12.1.3 Global Forecasted Price of Radiopharmaceuticals for Diagnosis by Type (2026-2033)
12.2 Global Radiopharmaceuticals for Diagnosis Market Forecast by Application (2026-2033)
12.2.1 Global Radiopharmaceuticals for Diagnosis Sales (K MT) Forecast by Application
12.2.2 Global Radiopharmaceuticals for Diagnosis Market Size (M USD) Forecast by Application (2026-2033)
13 CONCLUSION AND KEY FINDINGS
1.1 Market Definition and Statistical Scope of Radiopharmaceuticals for Diagnosis
1.2 Key Market Segments
1.2.1 Radiopharmaceuticals for Diagnosis Segment by Type
1.2.2 Radiopharmaceuticals for Diagnosis Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 RADIOPHARMACEUTICALS FOR DIAGNOSIS MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Radiopharmaceuticals for Diagnosis Market Size (M USD) Estimates and Forecasts (2020-2033)
2.1.2 Global Radiopharmaceuticals for Diagnosis Sales Estimates and Forecasts (2020-2033)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 RADIOPHARMACEUTICALS FOR DIAGNOSIS MARKET COMPETITIVE LANDSCAPE
3.1 Company Assessment Quadrant
3.2 Global Radiopharmaceuticals for Diagnosis Product Life Cycle
3.3 Global Radiopharmaceuticals for Diagnosis Sales by Manufacturers (2020-2025)
3.4 Global Radiopharmaceuticals for Diagnosis Revenue Market Share by Manufacturers (2020-2025)
3.5 Radiopharmaceuticals for Diagnosis Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Radiopharmaceuticals for Diagnosis Average Price by Manufacturers (2020-2025)
3.7 Manufacturers’ Manufacturing Sites, Areas Served, and Product Types
3.8 Radiopharmaceuticals for Diagnosis Market Competitive Situation and Trends
3.8.1 Radiopharmaceuticals for Diagnosis Market Concentration Rate
3.8.2 Global 5 and 10 Largest Radiopharmaceuticals for Diagnosis Players Market Share by Revenue
3.8.3 Mergers & Acquisitions, Expansion
4 RADIOPHARMACEUTICALS FOR DIAGNOSIS INDUSTRY CHAIN ANALYSIS
4.1 Radiopharmaceuticals for Diagnosis Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF RADIOPHARMACEUTICALS FOR DIAGNOSIS MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global Radiopharmaceuticals for Diagnosis Market Porter's Five Forces Analysis
5.6.1 Global Trade Frictions
5.6.2 U.S. Tariff Policy – April 2025
5.6.3 Global Trade Frictions and Their Impacts to Radiopharmaceuticals for Diagnosis Market
5.7 ESG Ratings of Leading Companies
6 RADIOPHARMACEUTICALS FOR DIAGNOSIS MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Radiopharmaceuticals for Diagnosis Sales Market Share by Type (2020-2025)
6.3 Global Radiopharmaceuticals for Diagnosis Market Size Market Share by Type (2020-2025)
6.4 Global Radiopharmaceuticals for Diagnosis Price by Type (2020-2025)
7 RADIOPHARMACEUTICALS FOR DIAGNOSIS MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Radiopharmaceuticals for Diagnosis Market Sales by Application (2020-2025)
7.3 Global Radiopharmaceuticals for Diagnosis Market Size (M USD) by Application (2020-2025)
7.4 Global Radiopharmaceuticals for Diagnosis Sales Growth Rate by Application (2020-2025)
8 RADIOPHARMACEUTICALS FOR DIAGNOSIS MARKET SALES BY REGION
8.1 Global Radiopharmaceuticals for Diagnosis Sales by Region
8.1.1 Global Radiopharmaceuticals for Diagnosis Sales by Region
8.1.2 Global Radiopharmaceuticals for Diagnosis Sales Market Share by Region
8.2 Global Radiopharmaceuticals for Diagnosis Market Size by Region
8.2.1 Global Radiopharmaceuticals for Diagnosis Market Size by Region
8.2.2 Global Radiopharmaceuticals for Diagnosis Market Size Market Share by Region
8.3 North America
8.3.1 North America Radiopharmaceuticals for Diagnosis Sales by Country
8.3.2 North America Radiopharmaceuticals for Diagnosis Market Size by Country
8.3.3 U.S. Market Overview
8.3.4 Canada Market Overview
8.3.5 Mexico Market Overview
8.4 Europe
8.4.1 Europe Radiopharmaceuticals for Diagnosis Sales by Country
8.4.2 Europe Radiopharmaceuticals for Diagnosis Market Size by Country
8.4.3 Germany Market Overview
8.4.4 France Market Overview
8.4.5 U.K. Market Overview
8.4.6 Italy Market Overview
8.4.7 Spain Market Overview
8.5 Asia Pacific
8.5.1 Asia Pacific Radiopharmaceuticals for Diagnosis Sales by Region
8.5.2 Asia Pacific Radiopharmaceuticals for Diagnosis Market Size by Region
8.5.3 China Market Overview
8.5.4 Japan Market Overview
8.5.5 South Korea Market Overview
8.5.6 India Market Overview
8.5.7 Southeast Asia Market Overview
8.6 South America
8.6.1 South America Radiopharmaceuticals for Diagnosis Sales by Country
8.6.2 South America Radiopharmaceuticals for Diagnosis Market Size by Country
8.6.3 Brazil Market Overview
8.6.4 Argentina Market Overview
8.6.5 Columbia Market Overview
8.7 Middle East and Africa
8.7.1 Middle East and Africa Radiopharmaceuticals for Diagnosis Sales by Region
8.7.2 Middle East and Africa Radiopharmaceuticals for Diagnosis Market Size by Region
8.7.3 Saudi Arabia Market Overview
8.7.4 UAE Market Overview
8.7.5 Egypt Market Overview
8.7.6 Nigeria Market Overview
8.7.7 South Africa Market Overview
9 RADIOPHARMACEUTICALS FOR DIAGNOSIS MARKET PRODUCTION BY REGION
9.1 Global Production of Radiopharmaceuticals for Diagnosis by Region(2020-2025)
9.2 Global Radiopharmaceuticals for Diagnosis Revenue Market Share by Region (2020-2025)
9.3 Global Radiopharmaceuticals for Diagnosis Production, Revenue, Price and Gross Margin (2020-2025)
9.4 North America Radiopharmaceuticals for Diagnosis Production
9.4.1 North America Radiopharmaceuticals for Diagnosis Production Growth Rate (2020-2025)
9.4.2 North America Radiopharmaceuticals for Diagnosis Production, Revenue, Price and Gross Margin (2020-2025)
9.5 Europe Radiopharmaceuticals for Diagnosis Production
9.5.1 Europe Radiopharmaceuticals for Diagnosis Production Growth Rate (2020-2025)
9.5.2 Europe Radiopharmaceuticals for Diagnosis Production, Revenue, Price and Gross Margin (2020-2025)
9.6 Japan Radiopharmaceuticals for Diagnosis Production (2020-2025)
9.6.1 Japan Radiopharmaceuticals for Diagnosis Production Growth Rate (2020-2025)
9.6.2 Japan Radiopharmaceuticals for Diagnosis Production, Revenue, Price and Gross Margin (2020-2025)
9.7 China Radiopharmaceuticals for Diagnosis Production (2020-2025)
9.7.1 China Radiopharmaceuticals for Diagnosis Production Growth Rate (2020-2025)
9.7.2 China Radiopharmaceuticals for Diagnosis Production, Revenue, Price and Gross Margin (2020-2025)
10 KEY COMPANIES PROFILE
10.1 Atom High-tech Co.
10.1.1 Atom High-tech Co. Basic Information
10.1.2 Atom High-tech Co. Radiopharmaceuticals for Diagnosis Product Overview
10.1.3 Atom High-tech Co. Radiopharmaceuticals for Diagnosis Product Market Performance
10.1.4 Atom High-tech Co. Business Overview
10.1.5 Atom High-tech Co. SWOT Analysis
10.1.6 Atom High-tech Co. Recent Developments
10.2 Ltd.
10.2.1 Ltd. Basic Information
10.2.2 Ltd. Radiopharmaceuticals for Diagnosis Product Overview
10.2.3 Ltd. Radiopharmaceuticals for Diagnosis Product Market Performance
10.2.4 Ltd. Business Overview
10.2.5 Ltd. SWOT Analysis
10.2.6 Ltd. Recent Developments
10.3 Shanghai Xinke Pharmaceutical Co.
10.3.1 Shanghai Xinke Pharmaceutical Co. Basic Information
10.3.2 Shanghai Xinke Pharmaceutical Co. Radiopharmaceuticals for Diagnosis Product Overview
10.3.3 Shanghai Xinke Pharmaceutical Co. Radiopharmaceuticals for Diagnosis Product Market Performance
10.3.4 Shanghai Xinke Pharmaceutical Co. Business Overview
10.3.5 Shanghai Xinke Pharmaceutical Co. SWOT Analysis
10.3.6 Shanghai Xinke Pharmaceutical Co. Recent Developments
10.4 Ltd.
10.4.1 Ltd. Basic Information
10.4.2 Ltd. Radiopharmaceuticals for Diagnosis Product Overview
10.4.3 Ltd. Radiopharmaceuticals for Diagnosis Product Market Performance
10.4.4 Ltd. Business Overview
10.4.5 Ltd. Recent Developments
10.5 Guangdong Xi'ai Pharmaceutical Co.
10.5.1 Guangdong Xi'ai Pharmaceutical Co. Basic Information
10.5.2 Guangdong Xi'ai Pharmaceutical Co. Radiopharmaceuticals for Diagnosis Product Overview
10.5.3 Guangdong Xi'ai Pharmaceutical Co. Radiopharmaceuticals for Diagnosis Product Market Performance
10.5.4 Guangdong Xi'ai Pharmaceutical Co. Business Overview
10.5.5 Guangdong Xi'ai Pharmaceutical Co. Recent Developments
10.6 Ltd.
10.6.1 Ltd. Basic Information
10.6.2 Ltd. Radiopharmaceuticals for Diagnosis Product Overview
10.6.3 Ltd. Radiopharmaceuticals for Diagnosis Product Market Performance
10.6.4 Ltd. Business Overview
10.6.5 Ltd. Recent Developments
10.7 Wuxi Jiangyuan Industrial Technology and Trade Co.
10.7.1 Wuxi Jiangyuan Industrial Technology and Trade Co. Basic Information
10.7.2 Wuxi Jiangyuan Industrial Technology and Trade Co. Radiopharmaceuticals for Diagnosis Product Overview
10.7.3 Wuxi Jiangyuan Industrial Technology and Trade Co. Radiopharmaceuticals for Diagnosis Product Market Performance
10.7.4 Wuxi Jiangyuan Industrial Technology and Trade Co. Business Overview
10.7.5 Wuxi Jiangyuan Industrial Technology and Trade Co. Recent Developments
10.8 Ltd. Jiangyuan Pharmaceutical Factory
10.8.1 Ltd. Jiangyuan Pharmaceutical Factory Basic Information
10.8.2 Ltd. Jiangyuan Pharmaceutical Factory Radiopharmaceuticals for Diagnosis Product Overview
10.8.3 Ltd. Jiangyuan Pharmaceutical Factory Radiopharmaceuticals for Diagnosis Product Market Performance
10.8.4 Ltd. Jiangyuan Pharmaceutical Factory Business Overview
10.8.5 Ltd. Jiangyuan Pharmaceutical Factory Recent Developments
10.9 Guangzhou Atom High-tech Isotope Pharmaceutical Co.
10.9.1 Guangzhou Atom High-tech Isotope Pharmaceutical Co. Basic Information
10.9.2 Guangzhou Atom High-tech Isotope Pharmaceutical Co. Radiopharmaceuticals for Diagnosis Product Overview
10.9.3 Guangzhou Atom High-tech Isotope Pharmaceutical Co. Radiopharmaceuticals for Diagnosis Product Market Performance
10.9.4 Guangzhou Atom High-tech Isotope Pharmaceutical Co. Business Overview
10.9.5 Guangzhou Atom High-tech Isotope Pharmaceutical Co. Recent Developments
10.10 Ltd.
10.10.1 Ltd. Basic Information
10.10.2 Ltd. Radiopharmaceuticals for Diagnosis Product Overview
10.10.3 Ltd. Radiopharmaceuticals for Diagnosis Product Market Performance
10.10.4 Ltd. Business Overview
10.10.5 Ltd. Recent Developments
10.11 Chengdu Yunke Pharmaceutical Co.
10.11.1 Chengdu Yunke Pharmaceutical Co. Basic Information
10.11.2 Chengdu Yunke Pharmaceutical Co. Radiopharmaceuticals for Diagnosis Product Overview
10.11.3 Chengdu Yunke Pharmaceutical Co. Radiopharmaceuticals for Diagnosis Product Market Performance
10.11.4 Chengdu Yunke Pharmaceutical Co. Business Overview
10.11.5 Chengdu Yunke Pharmaceutical Co. Recent Developments
10.12 Ltd.
10.12.1 Ltd. Basic Information
10.12.2 Ltd. Radiopharmaceuticals for Diagnosis Product Overview
10.12.3 Ltd. Radiopharmaceuticals for Diagnosis Product Market Performance
10.12.4 Ltd. Business Overview
10.12.5 Ltd. Recent Developments
10.13 Shanghai Atom Kexing Pharmaceutical Co.
10.13.1 Shanghai Atom Kexing Pharmaceutical Co. Basic Information
10.13.2 Shanghai Atom Kexing Pharmaceutical Co. Radiopharmaceuticals for Diagnosis Product Overview
10.13.3 Shanghai Atom Kexing Pharmaceutical Co. Radiopharmaceuticals for Diagnosis Product Market Performance
10.13.4 Shanghai Atom Kexing Pharmaceutical Co. Business Overview
10.13.5 Shanghai Atom Kexing Pharmaceutical Co. Recent Developments
10.14 Ltd.
10.14.1 Ltd. Basic Information
10.14.2 Ltd. Radiopharmaceuticals for Diagnosis Product Overview
10.14.3 Ltd. Radiopharmaceuticals for Diagnosis Product Market Performance
10.14.4 Ltd. Business Overview
10.14.5 Ltd. Recent Developments
10.15 Shenzhen Larven Bioengineering Technology Co.
10.15.1 Shenzhen Larven Bioengineering Technology Co. Basic Information
10.15.2 Shenzhen Larven Bioengineering Technology Co. Radiopharmaceuticals for Diagnosis Product Overview
10.15.3 Shenzhen Larven Bioengineering Technology Co. Radiopharmaceuticals for Diagnosis Product Market Performance
10.15.4 Shenzhen Larven Bioengineering Technology Co. Business Overview
10.15.5 Shenzhen Larven Bioengineering Technology Co. Recent Developments
10.16 Ltd.
10.16.1 Ltd. Basic Information
10.16.2 Ltd. Radiopharmaceuticals for Diagnosis Product Overview
10.16.3 Ltd. Radiopharmaceuticals for Diagnosis Product Market Performance
10.16.4 Ltd. Business Overview
10.16.5 Ltd. Recent Developments
10.17 Ningbo Jun'an Pharmaceutical Technology Co.
10.17.1 Ningbo Jun'an Pharmaceutical Technology Co. Basic Information
10.17.2 Ningbo Jun'an Pharmaceutical Technology Co. Radiopharmaceuticals for Diagnosis Product Overview
10.17.3 Ningbo Jun'an Pharmaceutical Technology Co. Radiopharmaceuticals for Diagnosis Product Market Performance
10.17.4 Ningbo Jun'an Pharmaceutical Technology Co. Business Overview
10.17.5 Ningbo Jun'an Pharmaceutical Technology Co. Recent Developments
10.18 Ltd.
10.18.1 Ltd. Basic Information
10.18.2 Ltd. Radiopharmaceuticals for Diagnosis Product Overview
10.18.3 Ltd. Radiopharmaceuticals for Diagnosis Product Market Performance
10.18.4 Ltd. Business Overview
10.18.5 Ltd. Recent Developments
10.19 Beijing Zhibo High-tech Biotechnology Co.
10.19.1 Beijing Zhibo High-tech Biotechnology Co. Basic Information
10.19.2 Beijing Zhibo High-tech Biotechnology Co. Radiopharmaceuticals for Diagnosis Product Overview
10.19.3 Beijing Zhibo High-tech Biotechnology Co. Radiopharmaceuticals for Diagnosis Product Market Performance
10.19.4 Beijing Zhibo High-tech Biotechnology Co. Business Overview
10.19.5 Beijing Zhibo High-tech Biotechnology Co. Recent Developments
10.20 Ltd.
10.20.1 Ltd. Basic Information
10.20.2 Ltd. Radiopharmaceuticals for Diagnosis Product Overview
10.20.3 Ltd. Radiopharmaceuticals for Diagnosis Product Market Performance
10.20.4 Ltd. Business Overview
10.20.5 Ltd. Recent Developments
10.21 Tianjin Said Biopharmaceutical Co.
10.21.1 Tianjin Said Biopharmaceutical Co. Basic Information
10.21.2 Tianjin Said Biopharmaceutical Co. Radiopharmaceuticals for Diagnosis Product Overview
10.21.3 Tianjin Said Biopharmaceutical Co. Radiopharmaceuticals for Diagnosis Product Market Performance
10.21.4 Tianjin Said Biopharmaceutical Co. Business Overview
10.21.5 Tianjin Said Biopharmaceutical Co. Recent Developments
10.22 Ltd.
10.22.1 Ltd. Basic Information
10.22.2 Ltd. Radiopharmaceuticals for Diagnosis Product Overview
10.22.3 Ltd. Radiopharmaceuticals for Diagnosis Product Market Performance
10.22.4 Ltd. Business Overview
10.22.5 Ltd. Recent Developments
10.23 Chengdu Zhonghe Gaotong Isotope Co.
10.23.1 Chengdu Zhonghe Gaotong Isotope Co. Basic Information
10.23.2 Chengdu Zhonghe Gaotong Isotope Co. Radiopharmaceuticals for Diagnosis Product Overview
10.23.3 Chengdu Zhonghe Gaotong Isotope Co. Radiopharmaceuticals for Diagnosis Product Market Performance
10.23.4 Chengdu Zhonghe Gaotong Isotope Co. Business Overview
10.23.5 Chengdu Zhonghe Gaotong Isotope Co. Recent Developments
10.24 Ltd.
10.24.1 Ltd. Basic Information
10.24.2 Ltd. Radiopharmaceuticals for Diagnosis Product Overview
10.24.3 Ltd. Radiopharmaceuticals for Diagnosis Product Market Performance
10.24.4 Ltd. Business Overview
10.24.5 Ltd. Recent Developments
10.25 Chengdu Xinke Pharmaceutical Co.
10.25.1 Chengdu Xinke Pharmaceutical Co. Basic Information
10.25.2 Chengdu Xinke Pharmaceutical Co. Radiopharmaceuticals for Diagnosis Product Overview
10.25.3 Chengdu Xinke Pharmaceutical Co. Radiopharmaceuticals for Diagnosis Product Market Performance
10.25.4 Chengdu Xinke Pharmaceutical Co. Business Overview
10.25.5 Chengdu Xinke Pharmaceutical Co. Recent Developments
10.26 Ltd.
10.26.1 Ltd. Basic Information
10.26.2 Ltd. Radiopharmaceuticals for Diagnosis Product Overview
10.26.3 Ltd. Radiopharmaceuticals for Diagnosis Product Market Performance
10.26.4 Ltd. Business Overview
10.26.5 Ltd. Recent Developments
10.27 Jubilant Radiopharma
10.27.1 Jubilant Radiopharma Basic Information
10.27.2 Jubilant Radiopharma Radiopharmaceuticals for Diagnosis Product Overview
10.27.3 Jubilant Radiopharma Radiopharmaceuticals for Diagnosis Product Market Performance
10.27.4 Jubilant Radiopharma Business Overview
10.27.5 Jubilant Radiopharma Recent Developments
10.28 PDRadiopharma Inc.
10.28.1 PDRadiopharma Inc. Basic Information
10.28.2 PDRadiopharma Inc. Radiopharmaceuticals for Diagnosis Product Overview
10.28.3 PDRadiopharma Inc. Radiopharmaceuticals for Diagnosis Product Market Performance
10.28.4 PDRadiopharma Inc. Business Overview
10.28.5 PDRadiopharma Inc. Recent Developments
10.29 GE Healthcare Ltd
10.29.1 GE Healthcare Ltd Basic Information
10.29.2 GE Healthcare Ltd Radiopharmaceuticals for Diagnosis Product Overview
10.29.3 GE Healthcare Ltd Radiopharmaceuticals for Diagnosis Product Market Performance
10.29.4 GE Healthcare Ltd Business Overview
10.29.5 GE Healthcare Ltd Recent Developments
10.30 DOE IP
10.30.1 DOE IP Basic Information
10.30.2 DOE IP Radiopharmaceuticals for Diagnosis Product Overview
10.30.3 DOE IP Radiopharmaceuticals for Diagnosis Product Market Performance
10.30.4 DOE IP Business Overview
10.30.5 DOE IP Recent Developments
11 RADIOPHARMACEUTICALS FOR DIAGNOSIS MARKET FORECAST BY REGION
11.1 Global Radiopharmaceuticals for Diagnosis Market Size Forecast
11.2 Global Radiopharmaceuticals for Diagnosis Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Radiopharmaceuticals for Diagnosis Market Size Forecast by Country
11.2.3 Asia Pacific Radiopharmaceuticals for Diagnosis Market Size Forecast by Region
11.2.4 South America Radiopharmaceuticals for Diagnosis Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Sales of Radiopharmaceuticals for Diagnosis by Country
12 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2033)
12.1 Global Radiopharmaceuticals for Diagnosis Market Forecast by Type (2026-2033)
12.1.1 Global Forecasted Sales of Radiopharmaceuticals for Diagnosis by Type (2026-2033)
12.1.2 Global Radiopharmaceuticals for Diagnosis Market Size Forecast by Type (2026-2033)
12.1.3 Global Forecasted Price of Radiopharmaceuticals for Diagnosis by Type (2026-2033)
12.2 Global Radiopharmaceuticals for Diagnosis Market Forecast by Application (2026-2033)
12.2.1 Global Radiopharmaceuticals for Diagnosis Sales (K MT) Forecast by Application
12.2.2 Global Radiopharmaceuticals for Diagnosis Market Size (M USD) Forecast by Application (2026-2033)
13 CONCLUSION AND KEY FINDINGS
LIST OF TABLES
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Radiopharmaceuticals for Diagnosis Market Size Comparison by Region (M USD)
Table 5. Global Radiopharmaceuticals for Diagnosis Sales (K MT) by Manufacturers (2020-2025)
Table 6. Global Radiopharmaceuticals for Diagnosis Sales Market Share by Manufacturers (2020-2025)
Table 7. Global Radiopharmaceuticals for Diagnosis Revenue (M USD) by Manufacturers (2020-2025)
Table 8. Global Radiopharmaceuticals for Diagnosis Revenue Share by Manufacturers (2020-2025)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Radiopharmaceuticals for Diagnosis as of 2024)
Table 10. Global Market Radiopharmaceuticals for Diagnosis Average Price (USD/MT) of Key Manufacturers (2020-2025)
Table 11. Manufacturers’ Manufacturing Sites, Areas Served
Table 12. Manufacturers’ Product Type
Table 13. Global Radiopharmaceuticals for Diagnosis Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Market Overview of Key Raw Materials
Table 16. Midstream Market Analysis
Table 17. Downstream Customer Analysis
Table 18. Key Development Trends
Table 19. Driving Factors
Table 20. Radiopharmaceuticals for Diagnosis Market Challenges
Table 21. Goldman Sachs' forecast real GDP growth rate for 2024-2026
Table 22. S&P Global ' Forecast Real GDP Growth Rate For 2024-2027
Table 23. World Bank ' Forecast Real GDP Growth Rate For 2024-2026
Table 24. The Tariff Rates Imposed by the United States on Major Commodity Trading Countries
Table 25. Global Radiopharmaceuticals for Diagnosis Sales by Type (K MT)
Table 26. Global Radiopharmaceuticals for Diagnosis Market Size by Type (M USD)
Table 27. Global Radiopharmaceuticals for Diagnosis Sales (K MT) by Type (2020-2025)
Table 28. Global Radiopharmaceuticals for Diagnosis Sales Market Share by Type (2020-2025)
Table 29. Global Radiopharmaceuticals for Diagnosis Market Size (M USD) by Type (2020-2025)
Table 30. Global Radiopharmaceuticals for Diagnosis Market Size Share by Type (2020-2025)
Table 31. Global Radiopharmaceuticals for Diagnosis Price (USD/MT) by Type (2020-2025)
Table 32. Global Radiopharmaceuticals for Diagnosis Sales (K MT) by Application
Table 33. Global Radiopharmaceuticals for Diagnosis Market Size by Application
Table 34. Global Radiopharmaceuticals for Diagnosis Sales by Application (2020-2025) & (K MT)
Table 35. Global Radiopharmaceuticals for Diagnosis Sales Market Share by Application (2020-2025)
Table 36. Global Radiopharmaceuticals for Diagnosis Market Size by Application (2020-2025) & (M USD)
Table 37. Global Radiopharmaceuticals for Diagnosis Market Share by Application (2020-2025)
Table 38. Global Radiopharmaceuticals for Diagnosis Sales Growth Rate by Application (2020-2025)
Table 39. Global Radiopharmaceuticals for Diagnosis Sales by Region (2020-2025) & (K MT)
Table 40. Global Radiopharmaceuticals for Diagnosis Sales Market Share by Region (2020-2025)
Table 41. Global Radiopharmaceuticals for Diagnosis Market Size by Region (2020-2025) & (M USD)
Table 42. Global Radiopharmaceuticals for Diagnosis Market Size Market Share by Region (2020-2025)
Table 43. North America Radiopharmaceuticals for Diagnosis Sales by Country (2020-2025) & (K MT)
Table 44. North America Radiopharmaceuticals for Diagnosis Market Size by Country (2020-2025) & (M USD)
Table 45. Europe Radiopharmaceuticals for Diagnosis Sales by Country (2020-2025) & (K MT)
Table 46. Europe Radiopharmaceuticals for Diagnosis Market Size by Country (2020-2025) & (M USD)
Table 47. Asia Pacific Radiopharmaceuticals for Diagnosis Sales by Region (2020-2025) & (K MT)
Table 48. Asia Pacific Radiopharmaceuticals for Diagnosis Market Size by Region (2020-2025) & (M USD)
Table 49. South America Radiopharmaceuticals for Diagnosis Sales by Country (2020-2025) & (K MT)
Table 50. South America Radiopharmaceuticals for Diagnosis Market Size by Country (2020-2025) & (M USD)
Table 51. Middle East and Africa Radiopharmaceuticals for Diagnosis Sales by Region (2020-2025) & (K MT)
Table 52. Middle East and Africa Radiopharmaceuticals for Diagnosis Market Size by Region (2020-2025) & (M USD)
Table 53. Global Radiopharmaceuticals for Diagnosis Production (K MT) by Region(2020-2025)
Table 54. Global Radiopharmaceuticals for Diagnosis Revenue (US$ Million) by Region (2020-2025)
Table 55. Global Radiopharmaceuticals for Diagnosis Revenue Market Share by Region (2020-2025)
Table 56. Global Radiopharmaceuticals for Diagnosis Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 57. North America Radiopharmaceuticals for Diagnosis Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 58. Europe Radiopharmaceuticals for Diagnosis Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 59. Japan Radiopharmaceuticals for Diagnosis Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 60. China Radiopharmaceuticals for Diagnosis Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 61. Atom High-tech Co. Basic Information
Table 62. Atom High-tech Co. Radiopharmaceuticals for Diagnosis Product Overview
Table 63. Atom High-tech Co. Radiopharmaceuticals for Diagnosis Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 64. Atom High-tech Co. Business Overview
Table 65. Atom High-tech Co. SWOT Analysis
Table 66. Atom High-tech Co. Recent Developments
Table 67. Ltd. Basic Information
Table 68. Ltd. Radiopharmaceuticals for Diagnosis Product Overview
Table 69. Ltd. Radiopharmaceuticals for Diagnosis Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 70. Ltd. Business Overview
Table 71. Ltd. SWOT Analysis
Table 72. Ltd. Recent Developments
Table 73. Shanghai Xinke Pharmaceutical Co. Basic Information
Table 74. Shanghai Xinke Pharmaceutical Co. Radiopharmaceuticals for Diagnosis Product Overview
Table 75. Shanghai Xinke Pharmaceutical Co. Radiopharmaceuticals for Diagnosis Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 76. Shanghai Xinke Pharmaceutical Co. Business Overview
Table 77. Shanghai Xinke Pharmaceutical Co. SWOT Analysis
Table 78. Shanghai Xinke Pharmaceutical Co. Recent Developments
Table 79. Ltd. Basic Information
Table 80. Ltd. Radiopharmaceuticals for Diagnosis Product Overview
Table 81. Ltd. Radiopharmaceuticals for Diagnosis Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 82. Ltd. Business Overview
Table 83. Ltd. Recent Developments
Table 84. Guangdong Xi'ai Pharmaceutical Co. Basic Information
Table 85. Guangdong Xi'ai Pharmaceutical Co. Radiopharmaceuticals for Diagnosis Product Overview
Table 86. Guangdong Xi'ai Pharmaceutical Co. Radiopharmaceuticals for Diagnosis Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 87. Guangdong Xi'ai Pharmaceutical Co. Business Overview
Table 88. Guangdong Xi'ai Pharmaceutical Co. Recent Developments
Table 89. Ltd. Basic Information
Table 90. Ltd. Radiopharmaceuticals for Diagnosis Product Overview
Table 91. Ltd. Radiopharmaceuticals for Diagnosis Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 92. Ltd. Business Overview
Table 93. Ltd. Recent Developments
Table 94. Wuxi Jiangyuan Industrial Technology and Trade Co. Basic Information
Table 95. Wuxi Jiangyuan Industrial Technology and Trade Co. Radiopharmaceuticals for Diagnosis Product Overview
Table 96. Wuxi Jiangyuan Industrial Technology and Trade Co. Radiopharmaceuticals for Diagnosis Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 97. Wuxi Jiangyuan Industrial Technology and Trade Co. Business Overview
Table 98. Wuxi Jiangyuan Industrial Technology and Trade Co. Recent Developments
Table 99. Ltd. Jiangyuan Pharmaceutical Factory Basic Information
Table 100. Ltd. Jiangyuan Pharmaceutical Factory Radiopharmaceuticals for Diagnosis Product Overview
Table 101. Ltd. Jiangyuan Pharmaceutical Factory Radiopharmaceuticals for Diagnosis Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 102. Ltd. Jiangyuan Pharmaceutical Factory Business Overview
Table 103. Ltd. Jiangyuan Pharmaceutical Factory Recent Developments
Table 104. Guangzhou Atom High-tech Isotope Pharmaceutical Co. Basic Information
Table 105. Guangzhou Atom High-tech Isotope Pharmaceutical Co. Radiopharmaceuticals for Diagnosis Product Overview
Table 106. Guangzhou Atom High-tech Isotope Pharmaceutical Co. Radiopharmaceuticals for Diagnosis Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 107. Guangzhou Atom High-tech Isotope Pharmaceutical Co. Business Overview
Table 108. Guangzhou Atom High-tech Isotope Pharmaceutical Co. Recent Developments
Table 109. Ltd. Basic Information
Table 110. Ltd. Radiopharmaceuticals for Diagnosis Product Overview
Table 111. Ltd. Radiopharmaceuticals for Diagnosis Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 112. Ltd. Business Overview
Table 113. Ltd. Recent Developments
Table 114. Chengdu Yunke Pharmaceutical Co. Basic Information
Table 115. Chengdu Yunke Pharmaceutical Co. Radiopharmaceuticals for Diagnosis Product Overview
Table 116. Chengdu Yunke Pharmaceutical Co. Radiopharmaceuticals for Diagnosis Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 117. Chengdu Yunke Pharmaceutical Co. Business Overview
Table 118. Chengdu Yunke Pharmaceutical Co. Recent Developments
Table 119. Ltd. Basic Information
Table 120. Ltd. Radiopharmaceuticals for Diagnosis Product Overview
Table 121. Ltd. Radiopharmaceuticals for Diagnosis Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 122. Ltd. Business Overview
Table 123. Ltd. Recent Developments
Table 124. Shanghai Atom Kexing Pharmaceutical Co. Basic Information
Table 125. Shanghai Atom Kexing Pharmaceutical Co. Radiopharmaceuticals for Diagnosis Product Overview
Table 126. Shanghai Atom Kexing Pharmaceutical Co. Radiopharmaceuticals for Diagnosis Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 127. Shanghai Atom Kexing Pharmaceutical Co. Business Overview
Table 128. Shanghai Atom Kexing Pharmaceutical Co. Recent Developments
Table 129. Ltd. Basic Information
Table 130. Ltd. Radiopharmaceuticals for Diagnosis Product Overview
Table 131. Ltd. Radiopharmaceuticals for Diagnosis Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 132. Ltd. Business Overview
Table 133. Ltd. Recent Developments
Table 134. Shenzhen Larven Bioengineering Technology Co. Basic Information
Table 135. Shenzhen Larven Bioengineering Technology Co. Radiopharmaceuticals for Diagnosis Product Overview
Table 136. Shenzhen Larven Bioengineering Technology Co. Radiopharmaceuticals for Diagnosis Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 137. Shenzhen Larven Bioengineering Technology Co. Business Overview
Table 138. Shenzhen Larven Bioengineering Technology Co. Recent Developments
Table 139. Ltd. Basic Information
Table 140. Ltd. Radiopharmaceuticals for Diagnosis Product Overview
Table 141. Ltd. Radiopharmaceuticals for Diagnosis Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 142. Ltd. Business Overview
Table 143. Ltd. Recent Developments
Table 144. Ningbo Jun'an Pharmaceutical Technology Co. Basic Information
Table 145. Ningbo Jun'an Pharmaceutical Technology Co. Radiopharmaceuticals for Diagnosis Product Overview
Table 146. Ningbo Jun'an Pharmaceutical Technology Co. Radiopharmaceuticals for Diagnosis Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 147. Ningbo Jun'an Pharmaceutical Technology Co. Business Overview
Table 148. Ningbo Jun'an Pharmaceutical Technology Co. Recent Developments
Table 149. Ltd. Basic Information
Table 150. Ltd. Radiopharmaceuticals for Diagnosis Product Overview
Table 151. Ltd. Radiopharmaceuticals for Diagnosis Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 152. Ltd. Business Overview
Table 153. Ltd. Recent Developments
Table 154. Beijing Zhibo High-tech Biotechnology Co. Basic Information
Table 155. Beijing Zhibo High-tech Biotechnology Co. Radiopharmaceuticals for Diagnosis Product Overview
Table 156. Beijing Zhibo High-tech Biotechnology Co. Radiopharmaceuticals for Diagnosis Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 157. Beijing Zhibo High-tech Biotechnology Co. Business Overview
Table 158. Beijing Zhibo High-tech Biotechnology Co. Recent Developments
Table 159. Ltd. Basic Information
Table 160. Ltd. Radiopharmaceuticals for Diagnosis Product Overview
Table 161. Ltd. Radiopharmaceuticals for Diagnosis Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 162. Ltd. Business Overview
Table 163. Ltd. Recent Developments
Table 164. Tianjin Said Biopharmaceutical Co. Basic Information
Table 165. Tianjin Said Biopharmaceutical Co. Radiopharmaceuticals for Diagnosis Product Overview
Table 166. Tianjin Said Biopharmaceutical Co. Radiopharmaceuticals for Diagnosis Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 167. Tianjin Said Biopharmaceutical Co. Business Overview
Table 168. Tianjin Said Biopharmaceutical Co. Recent Developments
Table 169. Ltd. Basic Information
Table 170. Ltd. Radiopharmaceuticals for Diagnosis Product Overview
Table 171. Ltd. Radiopharmaceuticals for Diagnosis Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 172. Ltd. Business Overview
Table 173. Ltd. Recent Developments
Table 174. Chengdu Zhonghe Gaotong Isotope Co. Basic Information
Table 175. Chengdu Zhonghe Gaotong Isotope Co. Radiopharmaceuticals for Diagnosis Product Overview
Table 176. Chengdu Zhonghe Gaotong Isotope Co. Radiopharmaceuticals for Diagnosis Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 177. Chengdu Zhonghe Gaotong Isotope Co. Business Overview
Table 178. Chengdu Zhonghe Gaotong Isotope Co. Recent Developments
Table 179. Ltd. Basic Information
Table 180. Ltd. Radiopharmaceuticals for Diagnosis Product Overview
Table 181. Ltd. Radiopharmaceuticals for Diagnosis Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 182. Ltd. Business Overview
Table 183. Ltd. Recent Developments
Table 184. Chengdu Xinke Pharmaceutical Co. Basic Information
Table 185. Chengdu Xinke Pharmaceutical Co. Radiopharmaceuticals for Diagnosis Product Overview
Table 186. Chengdu Xinke Pharmaceutical Co. Radiopharmaceuticals for Diagnosis Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 187. Chengdu Xinke Pharmaceutical Co. Business Overview
Table 188. Chengdu Xinke Pharmaceutical Co. Recent Developments
Table 189. Ltd. Basic Information
Table 190. Ltd. Radiopharmaceuticals for Diagnosis Product Overview
Table 191. Ltd. Radiopharmaceuticals for Diagnosis Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 192. Ltd. Business Overview
Table 193. Ltd. Recent Developments
Table 194. Jubilant Radiopharma Basic Information
Table 195. Jubilant Radiopharma Radiopharmaceuticals for Diagnosis Product Overview
Table 196. Jubilant Radiopharma Radiopharmaceuticals for Diagnosis Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 197. Jubilant Radiopharma Business Overview
Table 198. Jubilant Radiopharma Recent Developments
Table 199. PDRadiopharma Inc. Basic Information
Table 200. PDRadiopharma Inc. Radiopharmaceuticals for Diagnosis Product Overview
Table 201. PDRadiopharma Inc. Radiopharmaceuticals for Diagnosis Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 202. PDRadiopharma Inc. Business Overview
Table 203. PDRadiopharma Inc. Recent Developments
Table 204. GE Healthcare Ltd Basic Information
Table 205. GE Healthcare Ltd Radiopharmaceuticals for Diagnosis Product Overview
Table 206. GE Healthcare Ltd Radiopharmaceuticals for Diagnosis Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 207. GE Healthcare Ltd Business Overview
Table 208. GE Healthcare Ltd Recent Developments
Table 209. DOE IP Basic Information
Table 210. DOE IP Radiopharmaceuticals for Diagnosis Product Overview
Table 211. DOE IP Radiopharmaceuticals for Diagnosis Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 212. DOE IP Business Overview
Table 213. DOE IP Recent Developments
Table 214. Global Radiopharmaceuticals for Diagnosis Sales Forecast by Region (2026-2033) & (K MT)
Table 215. Global Radiopharmaceuticals for Diagnosis Market Size Forecast by Region (2026-2033) & (M USD)
Table 216. North America Radiopharmaceuticals for Diagnosis Sales Forecast by Country (2026-2033) & (K MT)
Table 217. North America Radiopharmaceuticals for Diagnosis Market Size Forecast by Country (2026-2033) & (M USD)
Table 218. Europe Radiopharmaceuticals for Diagnosis Sales Forecast by Country (2026-2033) & (K MT)
Table 219. Europe Radiopharmaceuticals for Diagnosis Market Size Forecast by Country (2026-2033) & (M USD)
Table 220. Asia Pacific Radiopharmaceuticals for Diagnosis Sales Forecast by Region (2026-2033) & (K MT)
Table 221. Asia Pacific Radiopharmaceuticals for Diagnosis Market Size Forecast by Region (2026-2033) & (M USD)
Table 222. South America Radiopharmaceuticals for Diagnosis Sales Forecast by Country (2026-2033) & (K MT)
Table 223. South America Radiopharmaceuticals for Diagnosis Market Size Forecast by Country (2026-2033) & (M USD)
Table 224. Middle East and Africa Radiopharmaceuticals for Diagnosis Sales Forecast by Country (2026-2033) & (Units)
Table 225. Middle East and Africa Radiopharmaceuticals for Diagnosis Market Size Forecast by Country (2026-2033) & (M USD)
Table 226. Global Radiopharmaceuticals for Diagnosis Sales Forecast by Type (2026-2033) & (K MT)
Table 227. Global Radiopharmaceuticals for Diagnosis Market Size Forecast by Type (2026-2033) & (M USD)
Table 228. Global Radiopharmaceuticals for Diagnosis Price Forecast by Type (2026-2033) & (USD/MT)
Table 229. Global Radiopharmaceuticals for Diagnosis Sales (K MT) Forecast by Application (2026-2033)
Table 230. Global Radiopharmaceuticals for Diagnosis Market Size Forecast by Application (2026-2033) & (M USD)
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Radiopharmaceuticals for Diagnosis Market Size Comparison by Region (M USD)
Table 5. Global Radiopharmaceuticals for Diagnosis Sales (K MT) by Manufacturers (2020-2025)
Table 6. Global Radiopharmaceuticals for Diagnosis Sales Market Share by Manufacturers (2020-2025)
Table 7. Global Radiopharmaceuticals for Diagnosis Revenue (M USD) by Manufacturers (2020-2025)
Table 8. Global Radiopharmaceuticals for Diagnosis Revenue Share by Manufacturers (2020-2025)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Radiopharmaceuticals for Diagnosis as of 2024)
Table 10. Global Market Radiopharmaceuticals for Diagnosis Average Price (USD/MT) of Key Manufacturers (2020-2025)
Table 11. Manufacturers’ Manufacturing Sites, Areas Served
Table 12. Manufacturers’ Product Type
Table 13. Global Radiopharmaceuticals for Diagnosis Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Market Overview of Key Raw Materials
Table 16. Midstream Market Analysis
Table 17. Downstream Customer Analysis
Table 18. Key Development Trends
Table 19. Driving Factors
Table 20. Radiopharmaceuticals for Diagnosis Market Challenges
Table 21. Goldman Sachs' forecast real GDP growth rate for 2024-2026
Table 22. S&P Global ' Forecast Real GDP Growth Rate For 2024-2027
Table 23. World Bank ' Forecast Real GDP Growth Rate For 2024-2026
Table 24. The Tariff Rates Imposed by the United States on Major Commodity Trading Countries
Table 25. Global Radiopharmaceuticals for Diagnosis Sales by Type (K MT)
Table 26. Global Radiopharmaceuticals for Diagnosis Market Size by Type (M USD)
Table 27. Global Radiopharmaceuticals for Diagnosis Sales (K MT) by Type (2020-2025)
Table 28. Global Radiopharmaceuticals for Diagnosis Sales Market Share by Type (2020-2025)
Table 29. Global Radiopharmaceuticals for Diagnosis Market Size (M USD) by Type (2020-2025)
Table 30. Global Radiopharmaceuticals for Diagnosis Market Size Share by Type (2020-2025)
Table 31. Global Radiopharmaceuticals for Diagnosis Price (USD/MT) by Type (2020-2025)
Table 32. Global Radiopharmaceuticals for Diagnosis Sales (K MT) by Application
Table 33. Global Radiopharmaceuticals for Diagnosis Market Size by Application
Table 34. Global Radiopharmaceuticals for Diagnosis Sales by Application (2020-2025) & (K MT)
Table 35. Global Radiopharmaceuticals for Diagnosis Sales Market Share by Application (2020-2025)
Table 36. Global Radiopharmaceuticals for Diagnosis Market Size by Application (2020-2025) & (M USD)
Table 37. Global Radiopharmaceuticals for Diagnosis Market Share by Application (2020-2025)
Table 38. Global Radiopharmaceuticals for Diagnosis Sales Growth Rate by Application (2020-2025)
Table 39. Global Radiopharmaceuticals for Diagnosis Sales by Region (2020-2025) & (K MT)
Table 40. Global Radiopharmaceuticals for Diagnosis Sales Market Share by Region (2020-2025)
Table 41. Global Radiopharmaceuticals for Diagnosis Market Size by Region (2020-2025) & (M USD)
Table 42. Global Radiopharmaceuticals for Diagnosis Market Size Market Share by Region (2020-2025)
Table 43. North America Radiopharmaceuticals for Diagnosis Sales by Country (2020-2025) & (K MT)
Table 44. North America Radiopharmaceuticals for Diagnosis Market Size by Country (2020-2025) & (M USD)
Table 45. Europe Radiopharmaceuticals for Diagnosis Sales by Country (2020-2025) & (K MT)
Table 46. Europe Radiopharmaceuticals for Diagnosis Market Size by Country (2020-2025) & (M USD)
Table 47. Asia Pacific Radiopharmaceuticals for Diagnosis Sales by Region (2020-2025) & (K MT)
Table 48. Asia Pacific Radiopharmaceuticals for Diagnosis Market Size by Region (2020-2025) & (M USD)
Table 49. South America Radiopharmaceuticals for Diagnosis Sales by Country (2020-2025) & (K MT)
Table 50. South America Radiopharmaceuticals for Diagnosis Market Size by Country (2020-2025) & (M USD)
Table 51. Middle East and Africa Radiopharmaceuticals for Diagnosis Sales by Region (2020-2025) & (K MT)
Table 52. Middle East and Africa Radiopharmaceuticals for Diagnosis Market Size by Region (2020-2025) & (M USD)
Table 53. Global Radiopharmaceuticals for Diagnosis Production (K MT) by Region(2020-2025)
Table 54. Global Radiopharmaceuticals for Diagnosis Revenue (US$ Million) by Region (2020-2025)
Table 55. Global Radiopharmaceuticals for Diagnosis Revenue Market Share by Region (2020-2025)
Table 56. Global Radiopharmaceuticals for Diagnosis Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 57. North America Radiopharmaceuticals for Diagnosis Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 58. Europe Radiopharmaceuticals for Diagnosis Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 59. Japan Radiopharmaceuticals for Diagnosis Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 60. China Radiopharmaceuticals for Diagnosis Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 61. Atom High-tech Co. Basic Information
Table 62. Atom High-tech Co. Radiopharmaceuticals for Diagnosis Product Overview
Table 63. Atom High-tech Co. Radiopharmaceuticals for Diagnosis Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 64. Atom High-tech Co. Business Overview
Table 65. Atom High-tech Co. SWOT Analysis
Table 66. Atom High-tech Co. Recent Developments
Table 67. Ltd. Basic Information
Table 68. Ltd. Radiopharmaceuticals for Diagnosis Product Overview
Table 69. Ltd. Radiopharmaceuticals for Diagnosis Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 70. Ltd. Business Overview
Table 71. Ltd. SWOT Analysis
Table 72. Ltd. Recent Developments
Table 73. Shanghai Xinke Pharmaceutical Co. Basic Information
Table 74. Shanghai Xinke Pharmaceutical Co. Radiopharmaceuticals for Diagnosis Product Overview
Table 75. Shanghai Xinke Pharmaceutical Co. Radiopharmaceuticals for Diagnosis Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 76. Shanghai Xinke Pharmaceutical Co. Business Overview
Table 77. Shanghai Xinke Pharmaceutical Co. SWOT Analysis
Table 78. Shanghai Xinke Pharmaceutical Co. Recent Developments
Table 79. Ltd. Basic Information
Table 80. Ltd. Radiopharmaceuticals for Diagnosis Product Overview
Table 81. Ltd. Radiopharmaceuticals for Diagnosis Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 82. Ltd. Business Overview
Table 83. Ltd. Recent Developments
Table 84. Guangdong Xi'ai Pharmaceutical Co. Basic Information
Table 85. Guangdong Xi'ai Pharmaceutical Co. Radiopharmaceuticals for Diagnosis Product Overview
Table 86. Guangdong Xi'ai Pharmaceutical Co. Radiopharmaceuticals for Diagnosis Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 87. Guangdong Xi'ai Pharmaceutical Co. Business Overview
Table 88. Guangdong Xi'ai Pharmaceutical Co. Recent Developments
Table 89. Ltd. Basic Information
Table 90. Ltd. Radiopharmaceuticals for Diagnosis Product Overview
Table 91. Ltd. Radiopharmaceuticals for Diagnosis Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 92. Ltd. Business Overview
Table 93. Ltd. Recent Developments
Table 94. Wuxi Jiangyuan Industrial Technology and Trade Co. Basic Information
Table 95. Wuxi Jiangyuan Industrial Technology and Trade Co. Radiopharmaceuticals for Diagnosis Product Overview
Table 96. Wuxi Jiangyuan Industrial Technology and Trade Co. Radiopharmaceuticals for Diagnosis Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 97. Wuxi Jiangyuan Industrial Technology and Trade Co. Business Overview
Table 98. Wuxi Jiangyuan Industrial Technology and Trade Co. Recent Developments
Table 99. Ltd. Jiangyuan Pharmaceutical Factory Basic Information
Table 100. Ltd. Jiangyuan Pharmaceutical Factory Radiopharmaceuticals for Diagnosis Product Overview
Table 101. Ltd. Jiangyuan Pharmaceutical Factory Radiopharmaceuticals for Diagnosis Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 102. Ltd. Jiangyuan Pharmaceutical Factory Business Overview
Table 103. Ltd. Jiangyuan Pharmaceutical Factory Recent Developments
Table 104. Guangzhou Atom High-tech Isotope Pharmaceutical Co. Basic Information
Table 105. Guangzhou Atom High-tech Isotope Pharmaceutical Co. Radiopharmaceuticals for Diagnosis Product Overview
Table 106. Guangzhou Atom High-tech Isotope Pharmaceutical Co. Radiopharmaceuticals for Diagnosis Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 107. Guangzhou Atom High-tech Isotope Pharmaceutical Co. Business Overview
Table 108. Guangzhou Atom High-tech Isotope Pharmaceutical Co. Recent Developments
Table 109. Ltd. Basic Information
Table 110. Ltd. Radiopharmaceuticals for Diagnosis Product Overview
Table 111. Ltd. Radiopharmaceuticals for Diagnosis Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 112. Ltd. Business Overview
Table 113. Ltd. Recent Developments
Table 114. Chengdu Yunke Pharmaceutical Co. Basic Information
Table 115. Chengdu Yunke Pharmaceutical Co. Radiopharmaceuticals for Diagnosis Product Overview
Table 116. Chengdu Yunke Pharmaceutical Co. Radiopharmaceuticals for Diagnosis Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 117. Chengdu Yunke Pharmaceutical Co. Business Overview
Table 118. Chengdu Yunke Pharmaceutical Co. Recent Developments
Table 119. Ltd. Basic Information
Table 120. Ltd. Radiopharmaceuticals for Diagnosis Product Overview
Table 121. Ltd. Radiopharmaceuticals for Diagnosis Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 122. Ltd. Business Overview
Table 123. Ltd. Recent Developments
Table 124. Shanghai Atom Kexing Pharmaceutical Co. Basic Information
Table 125. Shanghai Atom Kexing Pharmaceutical Co. Radiopharmaceuticals for Diagnosis Product Overview
Table 126. Shanghai Atom Kexing Pharmaceutical Co. Radiopharmaceuticals for Diagnosis Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 127. Shanghai Atom Kexing Pharmaceutical Co. Business Overview
Table 128. Shanghai Atom Kexing Pharmaceutical Co. Recent Developments
Table 129. Ltd. Basic Information
Table 130. Ltd. Radiopharmaceuticals for Diagnosis Product Overview
Table 131. Ltd. Radiopharmaceuticals for Diagnosis Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 132. Ltd. Business Overview
Table 133. Ltd. Recent Developments
Table 134. Shenzhen Larven Bioengineering Technology Co. Basic Information
Table 135. Shenzhen Larven Bioengineering Technology Co. Radiopharmaceuticals for Diagnosis Product Overview
Table 136. Shenzhen Larven Bioengineering Technology Co. Radiopharmaceuticals for Diagnosis Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 137. Shenzhen Larven Bioengineering Technology Co. Business Overview
Table 138. Shenzhen Larven Bioengineering Technology Co. Recent Developments
Table 139. Ltd. Basic Information
Table 140. Ltd. Radiopharmaceuticals for Diagnosis Product Overview
Table 141. Ltd. Radiopharmaceuticals for Diagnosis Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 142. Ltd. Business Overview
Table 143. Ltd. Recent Developments
Table 144. Ningbo Jun'an Pharmaceutical Technology Co. Basic Information
Table 145. Ningbo Jun'an Pharmaceutical Technology Co. Radiopharmaceuticals for Diagnosis Product Overview
Table 146. Ningbo Jun'an Pharmaceutical Technology Co. Radiopharmaceuticals for Diagnosis Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 147. Ningbo Jun'an Pharmaceutical Technology Co. Business Overview
Table 148. Ningbo Jun'an Pharmaceutical Technology Co. Recent Developments
Table 149. Ltd. Basic Information
Table 150. Ltd. Radiopharmaceuticals for Diagnosis Product Overview
Table 151. Ltd. Radiopharmaceuticals for Diagnosis Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 152. Ltd. Business Overview
Table 153. Ltd. Recent Developments
Table 154. Beijing Zhibo High-tech Biotechnology Co. Basic Information
Table 155. Beijing Zhibo High-tech Biotechnology Co. Radiopharmaceuticals for Diagnosis Product Overview
Table 156. Beijing Zhibo High-tech Biotechnology Co. Radiopharmaceuticals for Diagnosis Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 157. Beijing Zhibo High-tech Biotechnology Co. Business Overview
Table 158. Beijing Zhibo High-tech Biotechnology Co. Recent Developments
Table 159. Ltd. Basic Information
Table 160. Ltd. Radiopharmaceuticals for Diagnosis Product Overview
Table 161. Ltd. Radiopharmaceuticals for Diagnosis Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 162. Ltd. Business Overview
Table 163. Ltd. Recent Developments
Table 164. Tianjin Said Biopharmaceutical Co. Basic Information
Table 165. Tianjin Said Biopharmaceutical Co. Radiopharmaceuticals for Diagnosis Product Overview
Table 166. Tianjin Said Biopharmaceutical Co. Radiopharmaceuticals for Diagnosis Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 167. Tianjin Said Biopharmaceutical Co. Business Overview
Table 168. Tianjin Said Biopharmaceutical Co. Recent Developments
Table 169. Ltd. Basic Information
Table 170. Ltd. Radiopharmaceuticals for Diagnosis Product Overview
Table 171. Ltd. Radiopharmaceuticals for Diagnosis Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 172. Ltd. Business Overview
Table 173. Ltd. Recent Developments
Table 174. Chengdu Zhonghe Gaotong Isotope Co. Basic Information
Table 175. Chengdu Zhonghe Gaotong Isotope Co. Radiopharmaceuticals for Diagnosis Product Overview
Table 176. Chengdu Zhonghe Gaotong Isotope Co. Radiopharmaceuticals for Diagnosis Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 177. Chengdu Zhonghe Gaotong Isotope Co. Business Overview
Table 178. Chengdu Zhonghe Gaotong Isotope Co. Recent Developments
Table 179. Ltd. Basic Information
Table 180. Ltd. Radiopharmaceuticals for Diagnosis Product Overview
Table 181. Ltd. Radiopharmaceuticals for Diagnosis Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 182. Ltd. Business Overview
Table 183. Ltd. Recent Developments
Table 184. Chengdu Xinke Pharmaceutical Co. Basic Information
Table 185. Chengdu Xinke Pharmaceutical Co. Radiopharmaceuticals for Diagnosis Product Overview
Table 186. Chengdu Xinke Pharmaceutical Co. Radiopharmaceuticals for Diagnosis Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 187. Chengdu Xinke Pharmaceutical Co. Business Overview
Table 188. Chengdu Xinke Pharmaceutical Co. Recent Developments
Table 189. Ltd. Basic Information
Table 190. Ltd. Radiopharmaceuticals for Diagnosis Product Overview
Table 191. Ltd. Radiopharmaceuticals for Diagnosis Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 192. Ltd. Business Overview
Table 193. Ltd. Recent Developments
Table 194. Jubilant Radiopharma Basic Information
Table 195. Jubilant Radiopharma Radiopharmaceuticals for Diagnosis Product Overview
Table 196. Jubilant Radiopharma Radiopharmaceuticals for Diagnosis Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 197. Jubilant Radiopharma Business Overview
Table 198. Jubilant Radiopharma Recent Developments
Table 199. PDRadiopharma Inc. Basic Information
Table 200. PDRadiopharma Inc. Radiopharmaceuticals for Diagnosis Product Overview
Table 201. PDRadiopharma Inc. Radiopharmaceuticals for Diagnosis Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 202. PDRadiopharma Inc. Business Overview
Table 203. PDRadiopharma Inc. Recent Developments
Table 204. GE Healthcare Ltd Basic Information
Table 205. GE Healthcare Ltd Radiopharmaceuticals for Diagnosis Product Overview
Table 206. GE Healthcare Ltd Radiopharmaceuticals for Diagnosis Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 207. GE Healthcare Ltd Business Overview
Table 208. GE Healthcare Ltd Recent Developments
Table 209. DOE IP Basic Information
Table 210. DOE IP Radiopharmaceuticals for Diagnosis Product Overview
Table 211. DOE IP Radiopharmaceuticals for Diagnosis Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 212. DOE IP Business Overview
Table 213. DOE IP Recent Developments
Table 214. Global Radiopharmaceuticals for Diagnosis Sales Forecast by Region (2026-2033) & (K MT)
Table 215. Global Radiopharmaceuticals for Diagnosis Market Size Forecast by Region (2026-2033) & (M USD)
Table 216. North America Radiopharmaceuticals for Diagnosis Sales Forecast by Country (2026-2033) & (K MT)
Table 217. North America Radiopharmaceuticals for Diagnosis Market Size Forecast by Country (2026-2033) & (M USD)
Table 218. Europe Radiopharmaceuticals for Diagnosis Sales Forecast by Country (2026-2033) & (K MT)
Table 219. Europe Radiopharmaceuticals for Diagnosis Market Size Forecast by Country (2026-2033) & (M USD)
Table 220. Asia Pacific Radiopharmaceuticals for Diagnosis Sales Forecast by Region (2026-2033) & (K MT)
Table 221. Asia Pacific Radiopharmaceuticals for Diagnosis Market Size Forecast by Region (2026-2033) & (M USD)
Table 222. South America Radiopharmaceuticals for Diagnosis Sales Forecast by Country (2026-2033) & (K MT)
Table 223. South America Radiopharmaceuticals for Diagnosis Market Size Forecast by Country (2026-2033) & (M USD)
Table 224. Middle East and Africa Radiopharmaceuticals for Diagnosis Sales Forecast by Country (2026-2033) & (Units)
Table 225. Middle East and Africa Radiopharmaceuticals for Diagnosis Market Size Forecast by Country (2026-2033) & (M USD)
Table 226. Global Radiopharmaceuticals for Diagnosis Sales Forecast by Type (2026-2033) & (K MT)
Table 227. Global Radiopharmaceuticals for Diagnosis Market Size Forecast by Type (2026-2033) & (M USD)
Table 228. Global Radiopharmaceuticals for Diagnosis Price Forecast by Type (2026-2033) & (USD/MT)
Table 229. Global Radiopharmaceuticals for Diagnosis Sales (K MT) Forecast by Application (2026-2033)
Table 230. Global Radiopharmaceuticals for Diagnosis Market Size Forecast by Application (2026-2033) & (M USD)
LIST OF FIGURES
Figure 1. Product Picture of Radiopharmaceuticals for Diagnosis
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Radiopharmaceuticals for Diagnosis Market Size (M USD), 2024-2033
Figure 5. Global Radiopharmaceuticals for Diagnosis Market Size (M USD) (2020-2033)
Figure 6. Global Radiopharmaceuticals for Diagnosis Sales (K MT) & (2020-2033)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Radiopharmaceuticals for Diagnosis Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global Radiopharmaceuticals for Diagnosis Product Life Cycle
Figure 13. Radiopharmaceuticals for Diagnosis Sales Share by Manufacturers in 2024
Figure 14. Global Radiopharmaceuticals for Diagnosis Revenue Share by Manufacturers in 2024
Figure 15. Radiopharmaceuticals for Diagnosis Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2024
Figure 16. Global Market Radiopharmaceuticals for Diagnosis Average Price (USD/MT) of Key Manufacturers in 2024
Figure 17. The Global 5 and 10 Largest Players: Market Share by Radiopharmaceuticals for Diagnosis Revenue in 2024
Figure 18. Industry Chain Map of Radiopharmaceuticals for Diagnosis
Figure 19. Global Radiopharmaceuticals for Diagnosis Market PEST Analysis
Figure 20. Global Radiopharmaceuticals for Diagnosis Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 26. Global Radiopharmaceuticals for Diagnosis Market Share by Type
Figure 27. Sales Market Share of Radiopharmaceuticals for Diagnosis by Type (2020-2025)
Figure 28. Sales Market Share of Radiopharmaceuticals for Diagnosis by Type in 2024
Figure 29. Market Size Share of Radiopharmaceuticals for Diagnosis by Type (2020-2025)
Figure 30. Market Size Share of Radiopharmaceuticals for Diagnosis by Type in 2024
Figure 31. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 32. Global Radiopharmaceuticals for Diagnosis Market Share by Application
Figure 33. Global Radiopharmaceuticals for Diagnosis Sales Market Share by Application (2020-2025)
Figure 34. Global Radiopharmaceuticals for Diagnosis Sales Market Share by Application in 2024
Figure 35. Global Radiopharmaceuticals for Diagnosis Market Share by Application (2020-2025)
Figure 36. Global Radiopharmaceuticals for Diagnosis Market Share by Application in 2024
Figure 37. Global Radiopharmaceuticals for Diagnosis Sales Growth Rate by Application (2020-2025)
Figure 38. Global Radiopharmaceuticals for Diagnosis Sales Market Share by Region (2020-2025)
Figure 39. Global Radiopharmaceuticals for Diagnosis Market Size Market Share by Region (2020-2025)
Figure 40. North America Radiopharmaceuticals for Diagnosis Sales and Growth Rate (2020-2025) & (K MT)
Figure 41. North America Radiopharmaceuticals for Diagnosis Sales and Growth Rate (2020-2025) & (K MT)
Figure 42. North America Radiopharmaceuticals for Diagnosis Sales Market Share by Country in 2024
Figure 43. North America Radiopharmaceuticals for Diagnosis Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. North America Radiopharmaceuticals for Diagnosis Market Size Market Share by Country in 2024
Figure 45. U.S. Radiopharmaceuticals for Diagnosis Sales and Growth Rate (2020-2025) & (K MT)
Figure 46. U.S. Radiopharmaceuticals for Diagnosis Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. Canada Radiopharmaceuticals for Diagnosis Sales (K MT) and Growth Rate (2020-2025)
Figure 48. Canada Radiopharmaceuticals for Diagnosis Market Size (M USD) and Growth Rate (2020-2025)
Figure 49. Mexico Radiopharmaceuticals for Diagnosis Sales (Units) and Growth Rate (2020-2025)
Figure 50. Mexico Radiopharmaceuticals for Diagnosis Market Size (Units) and Growth Rate (2020-2025)
Figure 51. Europe Radiopharmaceuticals for Diagnosis Sales and Growth Rate (2020-2025) & (K MT)
Figure 52. Europe Radiopharmaceuticals for Diagnosis Sales Market Share by Country in 2024
Figure 53. Europe Radiopharmaceuticals for Diagnosis Market Size and Growth Rate (2020-2025) & (M USD)
Figure 54. Europe Radiopharmaceuticals for Diagnosis Market Size Market Share by Country in 2024
Figure 55. Germany Radiopharmaceuticals for Diagnosis Sales and Growth Rate (2020-2025) & (K MT)
Figure 56. Germany Radiopharmaceuticals for Diagnosis Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. France Radiopharmaceuticals for Diagnosis Sales and Growth Rate (2020-2025) & (K MT)
Figure 58. France Radiopharmaceuticals for Diagnosis Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. U.K. Radiopharmaceuticals for Diagnosis Sales and Growth Rate (2020-2025) & (K MT)
Figure 60. U.K. Radiopharmaceuticals for Diagnosis Market Size and Growth Rate (2020-2025) & (M USD)
Figure 61. Italy Radiopharmaceuticals for Diagnosis Sales and Growth Rate (2020-2025) & (K MT)
Figure 62. Italy Radiopharmaceuticals for Diagnosis Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Spain Radiopharmaceuticals for Diagnosis Sales and Growth Rate (2020-2025) & (K MT)
Figure 64. Spain Radiopharmaceuticals for Diagnosis Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. Asia Pacific Radiopharmaceuticals for Diagnosis Sales and Growth Rate (K MT)
Figure 66. Asia Pacific Radiopharmaceuticals for Diagnosis Sales Market Share by Region in 2024
Figure 67. Asia Pacific Radiopharmaceuticals for Diagnosis Market Size Market Share by Region in 2024
Figure 68. China Radiopharmaceuticals for Diagnosis Sales and Growth Rate (2020-2025) & (K MT)
Figure 69. China Radiopharmaceuticals for Diagnosis Market Size and Growth Rate (2020-2025) & (M USD)
Figure 70. Japan Radiopharmaceuticals for Diagnosis Sales and Growth Rate (2020-2025) & (K MT)
Figure 71. Japan Radiopharmaceuticals for Diagnosis Market Size and Growth Rate (2020-2025) & (M USD)
Figure 72. South Korea Radiopharmaceuticals for Diagnosis Sales and Growth Rate (2020-2025) & (K MT)
Figure 73. South Korea Radiopharmaceuticals for Diagnosis Market Size and Growth Rate (2020-2025) & (M USD)
Figure 74. India Radiopharmaceuticals for Diagnosis Sales and Growth Rate (2020-2025) & (K MT)
Figure 75. India Radiopharmaceuticals for Diagnosis Market Size and Growth Rate (2020-2025) & (M USD)
Figure 76. Southeast Asia Radiopharmaceuticals for Diagnosis Sales and Growth Rate (2020-2025) & (K MT)
Figure 77. Southeast Asia Radiopharmaceuticals for Diagnosis Market Size and Growth Rate (2020-2025) & (M USD)
Figure 78. South America Radiopharmaceuticals for Diagnosis Sales and Growth Rate (K MT)
Figure 79. South America Radiopharmaceuticals for Diagnosis Sales Market Share by Country in 2024
Figure 80. South America Radiopharmaceuticals for Diagnosis Market Size and Growth Rate (M USD)
Figure 81. South America Radiopharmaceuticals for Diagnosis Market Size Market Share by Country in 2024
Figure 82. Brazil Radiopharmaceuticals for Diagnosis Sales and Growth Rate (2020-2025) & (K MT)
Figure 83. Brazil Radiopharmaceuticals for Diagnosis Market Size and Growth Rate (2020-2025) & (M USD)
Figure 84. Argentina Radiopharmaceuticals for Diagnosis Sales and Growth Rate (2020-2025) & (K MT)
Figure 85. Argentina Radiopharmaceuticals for Diagnosis Market Size and Growth Rate (2020-2025) & (M USD)
Figure 86. Columbia Radiopharmaceuticals for Diagnosis Sales and Growth Rate (2020-2025) & (K MT)
Figure 87. Columbia Radiopharmaceuticals for Diagnosis Market Size and Growth Rate (2020-2025) & (M USD)
Figure 88. Middle East and Africa Radiopharmaceuticals for Diagnosis Sales and Growth Rate (K MT)
Figure 89. Middle East and Africa Radiopharmaceuticals for Diagnosis Sales Market Share by Region in 2024
Figure 90. Middle East and Africa Radiopharmaceuticals for Diagnosis Market Size and Growth Rate (M USD)
Figure 91. Middle East and Africa Radiopharmaceuticals for Diagnosis Market Size Market Share by Region in 2024
Figure 92. Saudi Arabia Radiopharmaceuticals for Diagnosis Sales and Growth Rate (2020-2025) & (K MT)
Figure 93. Saudi Arabia Radiopharmaceuticals for Diagnosis Market Size and Growth Rate (2020-2025) & (M USD)
Figure 94. UAE Radiopharmaceuticals for Diagnosis Sales and Growth Rate (2020-2025) & (K MT)
Figure 95. UAE Radiopharmaceuticals for Diagnosis Market Size and Growth Rate (2020-2025) & (M USD)
Figure 96. Egypt Radiopharmaceuticals for Diagnosis Sales and Growth Rate (2020-2025) & (K MT)
Figure 97. Egypt Radiopharmaceuticals for Diagnosis Market Size and Growth Rate (2020-2025) & (M USD)
Figure 98. Nigeria Radiopharmaceuticals for Diagnosis Sales and Growth Rate (2020-2025) & (K MT)
Figure 99. Nigeria Radiopharmaceuticals for Diagnosis Market Size and Growth Rate (2020-2025) & (M USD)
Figure 100. South Africa Radiopharmaceuticals for Diagnosis Sales and Growth Rate (2020-2025) & (K MT)
Figure 101. South Africa Radiopharmaceuticals for Diagnosis Market Size and Growth Rate (2020-2025) & (M USD)
Figure 102. Global Radiopharmaceuticals for Diagnosis Production Market Share by Region (2020-2025)
Figure 103. North America Radiopharmaceuticals for Diagnosis Production (K MT) Growth Rate (2020-2025)
Figure 104. Europe Radiopharmaceuticals for Diagnosis Production (K MT) Growth Rate (2020-2025)
Figure 105. Japan Radiopharmaceuticals for Diagnosis Production (K MT) Growth Rate (2020-2025)
Figure 106. China Radiopharmaceuticals for Diagnosis Production (K MT) Growth Rate (2020-2025)
Figure 107. Global Radiopharmaceuticals for Diagnosis Sales Forecast by Volume (2020-2033) & (K MT)
Figure 108. Global Radiopharmaceuticals for Diagnosis Market Size Forecast by Value (2020-2033) & (M USD)
Figure 109. Global Radiopharmaceuticals for Diagnosis Sales Market Share Forecast by Type (2026-2033)
Figure 110. Global Radiopharmaceuticals for Diagnosis Market Share Forecast by Type (2026-2033)
Figure 111. Global Radiopharmaceuticals for Diagnosis Sales Forecast by Application (2026-2033)
Figure 112. Global Radiopharmaceuticals for Diagnosis Market Share Forecast by Application (2026-2033)
Figure 1. Product Picture of Radiopharmaceuticals for Diagnosis
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Radiopharmaceuticals for Diagnosis Market Size (M USD), 2024-2033
Figure 5. Global Radiopharmaceuticals for Diagnosis Market Size (M USD) (2020-2033)
Figure 6. Global Radiopharmaceuticals for Diagnosis Sales (K MT) & (2020-2033)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Radiopharmaceuticals for Diagnosis Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global Radiopharmaceuticals for Diagnosis Product Life Cycle
Figure 13. Radiopharmaceuticals for Diagnosis Sales Share by Manufacturers in 2024
Figure 14. Global Radiopharmaceuticals for Diagnosis Revenue Share by Manufacturers in 2024
Figure 15. Radiopharmaceuticals for Diagnosis Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2024
Figure 16. Global Market Radiopharmaceuticals for Diagnosis Average Price (USD/MT) of Key Manufacturers in 2024
Figure 17. The Global 5 and 10 Largest Players: Market Share by Radiopharmaceuticals for Diagnosis Revenue in 2024
Figure 18. Industry Chain Map of Radiopharmaceuticals for Diagnosis
Figure 19. Global Radiopharmaceuticals for Diagnosis Market PEST Analysis
Figure 20. Global Radiopharmaceuticals for Diagnosis Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 26. Global Radiopharmaceuticals for Diagnosis Market Share by Type
Figure 27. Sales Market Share of Radiopharmaceuticals for Diagnosis by Type (2020-2025)
Figure 28. Sales Market Share of Radiopharmaceuticals for Diagnosis by Type in 2024
Figure 29. Market Size Share of Radiopharmaceuticals for Diagnosis by Type (2020-2025)
Figure 30. Market Size Share of Radiopharmaceuticals for Diagnosis by Type in 2024
Figure 31. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 32. Global Radiopharmaceuticals for Diagnosis Market Share by Application
Figure 33. Global Radiopharmaceuticals for Diagnosis Sales Market Share by Application (2020-2025)
Figure 34. Global Radiopharmaceuticals for Diagnosis Sales Market Share by Application in 2024
Figure 35. Global Radiopharmaceuticals for Diagnosis Market Share by Application (2020-2025)
Figure 36. Global Radiopharmaceuticals for Diagnosis Market Share by Application in 2024
Figure 37. Global Radiopharmaceuticals for Diagnosis Sales Growth Rate by Application (2020-2025)
Figure 38. Global Radiopharmaceuticals for Diagnosis Sales Market Share by Region (2020-2025)
Figure 39. Global Radiopharmaceuticals for Diagnosis Market Size Market Share by Region (2020-2025)
Figure 40. North America Radiopharmaceuticals for Diagnosis Sales and Growth Rate (2020-2025) & (K MT)
Figure 41. North America Radiopharmaceuticals for Diagnosis Sales and Growth Rate (2020-2025) & (K MT)
Figure 42. North America Radiopharmaceuticals for Diagnosis Sales Market Share by Country in 2024
Figure 43. North America Radiopharmaceuticals for Diagnosis Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. North America Radiopharmaceuticals for Diagnosis Market Size Market Share by Country in 2024
Figure 45. U.S. Radiopharmaceuticals for Diagnosis Sales and Growth Rate (2020-2025) & (K MT)
Figure 46. U.S. Radiopharmaceuticals for Diagnosis Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. Canada Radiopharmaceuticals for Diagnosis Sales (K MT) and Growth Rate (2020-2025)
Figure 48. Canada Radiopharmaceuticals for Diagnosis Market Size (M USD) and Growth Rate (2020-2025)
Figure 49. Mexico Radiopharmaceuticals for Diagnosis Sales (Units) and Growth Rate (2020-2025)
Figure 50. Mexico Radiopharmaceuticals for Diagnosis Market Size (Units) and Growth Rate (2020-2025)
Figure 51. Europe Radiopharmaceuticals for Diagnosis Sales and Growth Rate (2020-2025) & (K MT)
Figure 52. Europe Radiopharmaceuticals for Diagnosis Sales Market Share by Country in 2024
Figure 53. Europe Radiopharmaceuticals for Diagnosis Market Size and Growth Rate (2020-2025) & (M USD)
Figure 54. Europe Radiopharmaceuticals for Diagnosis Market Size Market Share by Country in 2024
Figure 55. Germany Radiopharmaceuticals for Diagnosis Sales and Growth Rate (2020-2025) & (K MT)
Figure 56. Germany Radiopharmaceuticals for Diagnosis Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. France Radiopharmaceuticals for Diagnosis Sales and Growth Rate (2020-2025) & (K MT)
Figure 58. France Radiopharmaceuticals for Diagnosis Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. U.K. Radiopharmaceuticals for Diagnosis Sales and Growth Rate (2020-2025) & (K MT)
Figure 60. U.K. Radiopharmaceuticals for Diagnosis Market Size and Growth Rate (2020-2025) & (M USD)
Figure 61. Italy Radiopharmaceuticals for Diagnosis Sales and Growth Rate (2020-2025) & (K MT)
Figure 62. Italy Radiopharmaceuticals for Diagnosis Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Spain Radiopharmaceuticals for Diagnosis Sales and Growth Rate (2020-2025) & (K MT)
Figure 64. Spain Radiopharmaceuticals for Diagnosis Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. Asia Pacific Radiopharmaceuticals for Diagnosis Sales and Growth Rate (K MT)
Figure 66. Asia Pacific Radiopharmaceuticals for Diagnosis Sales Market Share by Region in 2024
Figure 67. Asia Pacific Radiopharmaceuticals for Diagnosis Market Size Market Share by Region in 2024
Figure 68. China Radiopharmaceuticals for Diagnosis Sales and Growth Rate (2020-2025) & (K MT)
Figure 69. China Radiopharmaceuticals for Diagnosis Market Size and Growth Rate (2020-2025) & (M USD)
Figure 70. Japan Radiopharmaceuticals for Diagnosis Sales and Growth Rate (2020-2025) & (K MT)
Figure 71. Japan Radiopharmaceuticals for Diagnosis Market Size and Growth Rate (2020-2025) & (M USD)
Figure 72. South Korea Radiopharmaceuticals for Diagnosis Sales and Growth Rate (2020-2025) & (K MT)
Figure 73. South Korea Radiopharmaceuticals for Diagnosis Market Size and Growth Rate (2020-2025) & (M USD)
Figure 74. India Radiopharmaceuticals for Diagnosis Sales and Growth Rate (2020-2025) & (K MT)
Figure 75. India Radiopharmaceuticals for Diagnosis Market Size and Growth Rate (2020-2025) & (M USD)
Figure 76. Southeast Asia Radiopharmaceuticals for Diagnosis Sales and Growth Rate (2020-2025) & (K MT)
Figure 77. Southeast Asia Radiopharmaceuticals for Diagnosis Market Size and Growth Rate (2020-2025) & (M USD)
Figure 78. South America Radiopharmaceuticals for Diagnosis Sales and Growth Rate (K MT)
Figure 79. South America Radiopharmaceuticals for Diagnosis Sales Market Share by Country in 2024
Figure 80. South America Radiopharmaceuticals for Diagnosis Market Size and Growth Rate (M USD)
Figure 81. South America Radiopharmaceuticals for Diagnosis Market Size Market Share by Country in 2024
Figure 82. Brazil Radiopharmaceuticals for Diagnosis Sales and Growth Rate (2020-2025) & (K MT)
Figure 83. Brazil Radiopharmaceuticals for Diagnosis Market Size and Growth Rate (2020-2025) & (M USD)
Figure 84. Argentina Radiopharmaceuticals for Diagnosis Sales and Growth Rate (2020-2025) & (K MT)
Figure 85. Argentina Radiopharmaceuticals for Diagnosis Market Size and Growth Rate (2020-2025) & (M USD)
Figure 86. Columbia Radiopharmaceuticals for Diagnosis Sales and Growth Rate (2020-2025) & (K MT)
Figure 87. Columbia Radiopharmaceuticals for Diagnosis Market Size and Growth Rate (2020-2025) & (M USD)
Figure 88. Middle East and Africa Radiopharmaceuticals for Diagnosis Sales and Growth Rate (K MT)
Figure 89. Middle East and Africa Radiopharmaceuticals for Diagnosis Sales Market Share by Region in 2024
Figure 90. Middle East and Africa Radiopharmaceuticals for Diagnosis Market Size and Growth Rate (M USD)
Figure 91. Middle East and Africa Radiopharmaceuticals for Diagnosis Market Size Market Share by Region in 2024
Figure 92. Saudi Arabia Radiopharmaceuticals for Diagnosis Sales and Growth Rate (2020-2025) & (K MT)
Figure 93. Saudi Arabia Radiopharmaceuticals for Diagnosis Market Size and Growth Rate (2020-2025) & (M USD)
Figure 94. UAE Radiopharmaceuticals for Diagnosis Sales and Growth Rate (2020-2025) & (K MT)
Figure 95. UAE Radiopharmaceuticals for Diagnosis Market Size and Growth Rate (2020-2025) & (M USD)
Figure 96. Egypt Radiopharmaceuticals for Diagnosis Sales and Growth Rate (2020-2025) & (K MT)
Figure 97. Egypt Radiopharmaceuticals for Diagnosis Market Size and Growth Rate (2020-2025) & (M USD)
Figure 98. Nigeria Radiopharmaceuticals for Diagnosis Sales and Growth Rate (2020-2025) & (K MT)
Figure 99. Nigeria Radiopharmaceuticals for Diagnosis Market Size and Growth Rate (2020-2025) & (M USD)
Figure 100. South Africa Radiopharmaceuticals for Diagnosis Sales and Growth Rate (2020-2025) & (K MT)
Figure 101. South Africa Radiopharmaceuticals for Diagnosis Market Size and Growth Rate (2020-2025) & (M USD)
Figure 102. Global Radiopharmaceuticals for Diagnosis Production Market Share by Region (2020-2025)
Figure 103. North America Radiopharmaceuticals for Diagnosis Production (K MT) Growth Rate (2020-2025)
Figure 104. Europe Radiopharmaceuticals for Diagnosis Production (K MT) Growth Rate (2020-2025)
Figure 105. Japan Radiopharmaceuticals for Diagnosis Production (K MT) Growth Rate (2020-2025)
Figure 106. China Radiopharmaceuticals for Diagnosis Production (K MT) Growth Rate (2020-2025)
Figure 107. Global Radiopharmaceuticals for Diagnosis Sales Forecast by Volume (2020-2033) & (K MT)
Figure 108. Global Radiopharmaceuticals for Diagnosis Market Size Forecast by Value (2020-2033) & (M USD)
Figure 109. Global Radiopharmaceuticals for Diagnosis Sales Market Share Forecast by Type (2026-2033)
Figure 110. Global Radiopharmaceuticals for Diagnosis Market Share Forecast by Type (2026-2033)
Figure 111. Global Radiopharmaceuticals for Diagnosis Sales Forecast by Application (2026-2033)
Figure 112. Global Radiopharmaceuticals for Diagnosis Market Share Forecast by Application (2026-2033)
